{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:52:59Z","timestamp":1794567179363,"version":"4.9.1"},"reference-count":454,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303891"],"award-info":[{"award-number":["82303891"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203594"],"award-info":[{"award-number":["82203594"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473228"],"award-info":[{"award-number":["82473228"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303119"],"award-info":[{"award-number":["82303119"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472998"],"award-info":[{"award-number":["82472998"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011447","name":"Science and Technology Department of Henan Province","doi-asserted-by":"publisher","award":["232102310195"],"award-info":[{"award-number":["232102310195"]}],"id":[{"id":"10.13039\/501100011447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011447","name":"Science and Technology Department of Henan Province","doi-asserted-by":"publisher","award":["242102311082"],"award-info":[{"award-number":["242102311082"]}],"id":[{"id":"10.13039\/501100011447","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Post-Doctor Regulatory Commission","award":["GZB20230669"],"award-info":[{"award-number":["GZB20230669"]}]},{"name":"National Post-Doctor Regulatory Commission","award":["2024M763001"],"award-info":[{"award-number":["2024M763001"]}]},{"DOI":"10.13039\/501100009101","name":"Education Department of Henan Province","doi-asserted-by":"publisher","award":["23ZX007"],"award-info":[{"award-number":["23ZX007"]}],"id":[{"id":"10.13039\/501100009101","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Management Office of Key Research Projects in Higher Education Institutions in Henan Province","award":["24A310025"],"award-info":[{"award-number":["24A310025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02243-8","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:55:26Z","timestamp":1740380126000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":140,"title":["Inflammation in cancer: therapeutic opportunities from new insights"],"prefix":"10.1186","volume":"24","author":[{"given":"Yifei","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuer","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zigang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangdong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"2243_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539\u201345.","journal-title":"Lancet"},{"key":"2243_CR2","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrc3611","volume":"13","author":"E Elinav","year":"2013","unstructured":"Elinav E, Nowarski R, Thaiss CA, Hu B, Jin CC, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13:759\u201371.","journal-title":"Nat Rev Cancer"},{"key":"2243_CR3","first-page":"237","volume":"19","author":"DJ Propper","year":"2022","unstructured":"Propper DJ, Balkwill FR. Harnessing cytokines and chemokines for cancer therapy, Nature Reviews. Clin Oncol. 2022;19:237\u201353.","journal-title":"Clin Oncol"},{"key":"2243_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","volume":"9","author":"M Yi","year":"2024","unstructured":"Yi M, Li T, Niu M, Zhang H, Wu Y, Wu K, Dai Z. Targeting cytokine and chemokine signaling pathways for cancer therapy. Signal Transduct Tar. 2024;9:176.","journal-title":"Signal Transduct Tar"},{"key":"2243_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jconrel.2017.01.034","volume":"259","author":"KJ Isaacson","year":"2017","unstructured":"Isaacson KJ, Jensen MM, Subrahmanyam NB, Ghandehari H. Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression. J Control Release. 2017;259:62\u201375.","journal-title":"J Control Release"},{"key":"2243_CR6","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/bjc.2017.23","volume":"116","author":"C Yip","year":"2017","unstructured":"Yip C, Foidart P, Somja J, Truong A, Lienard M, Feyereisen E, Schroeder H, Gofflot S, Donneau AF, Collignon J, Delvenne P, Sounni NE, Jerusalem G, Noel A. MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib. Br J Cancer. 2017;116:742\u201351.","journal-title":"Br J Cancer"},{"key":"2243_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2628","volume":"9","author":"F Balkwill","year":"2009","unstructured":"Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009;9:361\u201371.","journal-title":"Nat Rev Cancer"},{"key":"2243_CR8","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.2337\/db15-0242","volume":"64","author":"BL Ke","year":"2015","unstructured":"Ke BL, Zhao ZY, Ye X, Gao ZG, Manganiello V, Wu B, Ye JP. Inactivation of NF-\u03baB p65 (RelA) in Liver Improves Insulin Sensitivity and Inhibits cAMP\/PKA Pathway. Diabetes. 2015;64:3355\u201362.","journal-title":"Diabetes"},{"key":"2243_CR9","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s12272-016-0795-8","volume":"39","author":"BH Kim","year":"2016","unstructured":"Kim BH, Yi EH, Ye SK. Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment. Arch Pharm Res. 2016;39:1085\u201399.","journal-title":"Arch Pharm Res"},{"key":"2243_CR10","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00204-015-1470-4","volume":"89","author":"F Li","year":"2015","unstructured":"Li F, Zhang JW, Arfuso F, Chinnathambi A, Zayed ME, Alharbi SA, Kumar AP, Ahn KS, Sethi G. NF-\u03baB in cancer therapy. Arch Toxicol. 2015;89:711\u201331.","journal-title":"Arch Toxicol"},{"key":"2243_CR11","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","volume":"376","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, Meade TW. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet. 2010;376:1741\u201350.","journal-title":"Lancet"},{"key":"2243_CR12","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/S0140-6736(20)30366-4","volume":"395","author":"J Burn","year":"2020","unstructured":"Burn J, Sheth H, Elliott F, Reed L, Macrae F, Mecklin JP, M\u00f6slein G, McRonald FE, Bertario L, Evans DG, Gerdes AM, Ho JWC, Lindblom A, Morrison PJ, Rashbass J, Ramesar R, Sepp\u00e4l\u00e4 T, Thomas HJW, Pylv\u00e4n\u00e4inen K, Borthwick GM, Mathers JC, Bishop DT, Investigators C. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial. Lancet. 2020;395:1855\u201363.","journal-title":"Lancet"},{"key":"2243_CR13","doi-asserted-by":"publisher","first-page":"836","DOI":"10.7326\/M16-0577","volume":"164","author":"K Bibbins-Domingo","year":"2016","unstructured":"Bibbins-Domingo K, Force UPST. Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2016;164:836-U103.","journal-title":"Ann Intern Med"},{"key":"2243_CR14","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.7150\/jca.16524","volume":"7","author":"PF Kong","year":"2016","unstructured":"Kong PF, Wu RY, Liu XC, Liu JJ, Chen SX, Ye MT, Yang CL, Song Z, He WZ, Yin CX, Yang Q, Jiang C, Liao FX, Peng RJ, Zhou ZW, Xu DZ, Xia LP. The effects of anti-inflammatory drug treatment in gastric cancer prevention: an update of a meta-analysis. J Cancer. 2016;7:2247\u201357.","journal-title":"J Cancer"},{"issue":"95","key":"2243_CR15","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1093\/jnci\/djg106","volume":"I","author":"WH Wang","year":"2003","unstructured":"Wang WH, Huang JQ, Zheng GF, Lam SK, Karlberg J, Wong BCY. Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. Jnci-J Natl Cancer. 2003;I(95):1784\u201391.","journal-title":"Jnci-J Natl Cancer"},{"key":"2243_CR16","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/sj.bjc.6604880","volume":"100","author":"CC Abnet","year":"2009","unstructured":"Abnet CC, Freedman ND, Kamangar F, Leitzmann MF, Hollenbeck AR, Schatzkin A. Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis. Br J Cancer. 2009;100:551\u20137.","journal-title":"Br J Cancer"},{"issue":"110","key":"2243_CR17","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/jnci\/djx267","volume":"I","author":"KS Cheung","year":"2018","unstructured":"Cheung KS, Chan EW, Wong AYS, Chen LJ, Seto WK, Wong ICK, Leung WK. Aspirin and risk of gastric cancer after eradication: a territory-wide study. Jnci-J Natl Cancer. 2018;I(110):743\u20139.","journal-title":"Jnci-J Natl Cancer"},{"key":"2243_CR18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ygyno.2017.10.026","volume":"148","author":"T Takiuchi","year":"2018","unstructured":"Takiuchi T, Blake EA, Matsuo K, Sood AK, Brasky TM. Aspirin use and endometrial cancer risk and survival. Gynecol Oncol. 2018;148:222\u201332.","journal-title":"Gynecol Oncol"},{"key":"2243_CR19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1089\/jwh.2022.0055","volume":"32","author":"YS Yang","year":"2023","unstructured":"Yang YS, Kornelius E, Lo SC, Wang YH, Huang CN. Aspirin and risk of specific breast cancer subtype in women with diabetes. J Womens Health. 2023;32:341\u20136.","journal-title":"J Womens Health"},{"key":"2243_CR20","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10654-023-00976-8","volume":"38","author":"L Lofling","year":"2023","unstructured":"Lofling L, Stoer NC, Nafisi S, Ursin G, Hofvind S, Botteri E. Low-dose aspirin and risk of breast cancer: a Norwegian population-based cohort study of one million women. Eur J Epidemiol. 2023;38:413\u201326.","journal-title":"Eur J Epidemiol"},{"key":"2243_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1053\/gast.2003.50008","volume":"124","author":"DA Corley","year":"2003","unstructured":"Corley DA, Kerlikowske K, Verma R, Buffler P. Protective association of aspirin\/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology. 2003;124:47\u201356.","journal-title":"Gastroenterology"},{"key":"2243_CR22","doi-asserted-by":"publisher","first-page":"e3112","DOI":"10.1038\/cddis.2017.513","volume":"8","author":"H Xia","year":"2017","unstructured":"Xia H, Hui KM. Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer. Cell DeathDis. 2017;8:e3112.","journal-title":"Cell DeathDis"},{"key":"2243_CR23","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41401-021-00738-w","volume":"43","author":"H Wang","year":"2022","unstructured":"Wang H, Chang Z, Cai GD, Yang P, Chen JH, Yang SS, Guo YF, Wang MY, Zheng XH, Lei JP, Liu PQ, Zhao DP, Wang JJ. The novel indomethacin derivative CZ-212-3 exerts antitumor effects on castration-resistant prostate cancer by degrading androgen receptor and its variants. Acta Pharmacol Sin. 2022;43:1024\u201332.","journal-title":"Acta Pharmacol Sin"},{"key":"2243_CR24","doi-asserted-by":"publisher","first-page":"e004938","DOI":"10.1136\/jitc-2022-004938","volume":"10","author":"NS Aboelella","year":"2022","unstructured":"Aboelella NS, Brandle C, Okoko O, Gazi MY, Ding ZC, Xu HY, Gorman G, Bollag R, Davila ML, Bryan LJ, Munn DH, Piazza GA, Zhou G. Indomethacin-induced oxidative stress enhances death receptor 5 signaling and sensitizes tumor cells to adoptive T-cell therapy. J Immunother Cancer. 2022;10:e004938.","journal-title":"J Immunother Cancer"},{"key":"2243_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.canlet.2009.02.018","volume":"281","author":"A Bernardi","year":"2009","unstructured":"Bernardi A, Braganhol E, J\u00e4ger E, Figueir\u00f3 F, Edelweiss MI, Pohlmann AR, Guterres SS, Battastini AMO. Indomethacin-loaded nanocapsules treatment reduces glioblastoma growth in a rat glioma model. Cancer Lett. 2009;281:53\u201363.","journal-title":"Cancer Lett"},{"key":"2243_CR26","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature07201","volume":"454","author":"R Medzhitov","year":"2008","unstructured":"Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454:428\u201335.","journal-title":"Nature"},{"key":"2243_CR27","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay C, Kushner I. Mechanisms of disease: acute-phase proteins and other systemic responses to inflammation. New Engl J Med. 1999;340:448\u201354.","journal-title":"New Engl J Med"},{"key":"2243_CR28","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/ni1330","volume":"7","author":"DL Drayton","year":"2006","unstructured":"Drayton DL, Liao S, Mounzer RH, Ruddle NH. Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol. 2006;7:344\u201353.","journal-title":"Nat Immunol"},{"key":"2243_CR29","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1172\/JCI34431","volume":"118","author":"GM Barton","year":"2008","unstructured":"Barton GM. A calculated response: control of inflammation by the innate immune system. J Clin Investig. 2008;118:413\u201320.","journal-title":"J Clin Investig"},{"key":"2243_CR30","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nri2171","volume":"7","author":"JS Pober","year":"2007","unstructured":"Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol. 2007;7:803\u201315.","journal-title":"Nat Rev Immunol"},{"key":"2243_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrc1782","volume":"6","author":"KE de Visser","year":"2006","unstructured":"de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006;6:24\u201337.","journal-title":"Nat Rev Cancer"},{"key":"2243_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51:27\u201341.","journal-title":"Immunity"},{"key":"2243_CR33","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1161\/ATVBAHA.120.314037","volume":"40","author":"LZ Sun","year":"2020","unstructured":"Sun LZ, Yang XF, Yuan ZY, Wang H. Metabolic reprogramming in immune response and tissue inflammation. Arterioscl Throm Vas. 2020;40:1990\u20132001.","journal-title":"Arterioscl Throm Vas"},{"key":"2243_CR34","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LAJ O'Neill","year":"2016","unstructured":"O\u2019Neill LAJ, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16:553\u201365.","journal-title":"Nat Rev Immunol"},{"key":"2243_CR35","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.3390\/nu15234999","volume":"15","author":"A Hatch-McChesney","year":"2023","unstructured":"Hatch-McChesney A, Smith TJ. Nutrition, immune function, and infectious disease in military personnel: a narrative review. Nutrients. 2023;15:4999.","journal-title":"Nutrients"},{"key":"2243_CR36","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1080\/10408398.2020.1792826","volume":"61","author":"L Barrea","year":"2021","unstructured":"Barrea L, Muscogiuri G, Frias-Toral E, Laudisio D, Pugliese G, Castellucci B, Garcia-Velasquez E, Savastano S, Colao A. Nutrition and immune system: from the Mediterranean diet to dietary supplementary through the microbiota. Crit Rev Food Sci. 2021;61:3066\u201390.","journal-title":"Crit Rev Food Sci"},{"key":"2243_CR37","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1249\/MSS.0000000000002604","volume":"53","author":"SE Harrison","year":"2021","unstructured":"Harrison SE, Oliver SJ, Kashi DS, Carswell AT, Edwards JP, Wentz LM, Roberts R, Tang JCY, Izard RM, Jackson S, Allan D, Rhodes LE, Fraser WD, Greeves JP, Walsh NP. Influence of vitamin D supplementation by simulated sunlight or oral D on respiratory infection during military training. Med Sci Sport Exer. 2021;53:1505\u201316.","journal-title":"Med Sci Sport Exer"},{"key":"2243_CR38","doi-asserted-by":"publisher","first-page":"975","DOI":"10.7205\/MILMED.170.11.975","volume":"170","author":"SM Wood","year":"2005","unstructured":"Wood SM, Kennedy JS, Arsenault JE, Thomas DL, Buck RH, Shippee RL, DeMichele SJ, Winship TR, Schaller JP, Montain S, Cordle CT. Novel nutritional immune formula maintains host defense mechanisms. Mil Med. 2005;170:975\u201385.","journal-title":"Mil Med"},{"key":"2243_CR39","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/oby.22831","volume":"28","author":"A Simonnet","year":"2020","unstructured":"Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, Labreuche J, Mathieu D, Pattou F, Jourdain M, Stud LLC-O. High prevalence of obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity. 2020;28:1195\u20139.","journal-title":"Obesity"},{"key":"2243_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3109\/09513590.2013.852531","volume":"30","author":"C Castelo-Branco","year":"2014","unstructured":"Castelo-Branco C, Soveral I. The immune system and aging: a review. Gynecol Endocrinol. 2014;30:16\u201322.","journal-title":"Gynecol Endocrinol"},{"key":"2243_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/CMR.00084-18","volume":"32","author":"P Zimmermann","year":"2019","unstructured":"Zimmermann P, Curtis N. Factors that influence the immune response to vaccination. Clin Microbiol Rev. 2019;32:10.","journal-title":"Clin Microbiol Rev"},{"key":"2243_CR42","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1001\/jamapediatrics.2017.0638","volume":"171","author":"M Voysey","year":"2017","unstructured":"Voysey M, Kelly DF, Fanshawe TR, Sadarangani M, O\u2019Brien KL, Perera R, Pollard AJ. The influence of maternally derived antibody and infant age at vaccination on infant vaccine responses an individual participant meta-analysis. Jama Pediatr. 2017;171:637\u201346.","journal-title":"Jama Pediatr"},{"key":"2243_CR43","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.it.2022.07.004","volume":"43","author":"D Capece","year":"2022","unstructured":"Capece D, Verzella D, Flati I, Arboretto P, Cornice J, Franzoso G. NF-?B: blending metabolism, immunity, and inflammation. Trends Immunol. 2022;43:757\u201375.","journal-title":"Trends Immunol"},{"key":"2243_CR44","first-page":"2233","volume":"14","author":"L F\u00e9s\u00fcs","year":"2011","unstructured":"F\u00e9s\u00fcs L, Dem\u00e9ny MA, Petrovski G. Autophagy shapes inflammation, antioxid redox. Sign. 2011;14:2233\u201343.","journal-title":"Sign"},{"key":"2243_CR45","doi-asserted-by":"publisher","first-page":"170040","DOI":"10.1183\/16000617.0040-2017","volume":"26","author":"FNK Kwong","year":"2017","unstructured":"Kwong FNK, Nicholson AG, Harrison CL, Hansbro PM, Adcock IM, Chung KF. Is mitochondrial dysfunction a driving mechanism linking COPD to nonsmall cell lung carcinoma? Eur Respir Rev. 2017;26:170040.","journal-title":"Eur Respir Rev"},{"key":"2243_CR46","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/15548627.2017.1402992","volume":"14","author":"V Deretic","year":"2018","unstructured":"Deretic V, Levine B. Autophagy balances inflammation in innate immunity. Autophagy. 2018;14:243\u201351.","journal-title":"Autophagy"},{"key":"2243_CR47","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41577-018-0095-2","volume":"19","author":"AJ Clarke","year":"2019","unstructured":"Clarke AJ, Simon AK. Autophagy in the renewal, differentiation and homeostasis of immune cells. Nat Rev Immunol. 2019;19:170\u201383.","journal-title":"Nat Rev Immunol"},{"key":"2243_CR48","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/15548627.2017.1362525","volume":"14","author":"T Riffelmacher","year":"2018","unstructured":"Riffelmacher T, Richter FC, Simon AK. Autophagy dictates metabolism and differentiation of inflammatory immune cells. Autophagy. 2018;14:199\u2013206.","journal-title":"Autophagy"},{"key":"2243_CR49","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nature06421","volume":"450","author":"MA Sanjuan","year":"2007","unstructured":"Sanjuan MA, Dillon CP, Tait SWG, Moshiach S, Dorsey F, Connell S, Komatsu M, Tanaka K, Cleveland JL, Withoff S, Green DR. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature. 2007;450:1253\u20137.","journal-title":"Nature"},{"key":"2243_CR50","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.cell.2020.11.033","volume":"183","author":"BL Heckmann","year":"2020","unstructured":"Heckmann BL, Teubner BJW, Tummers B, Boada-Romero E, Harris L, Yang M, Guy CS, Zakharenko SS, Green DR. LC3-associated endocytosis facilitates \u03b2-amyloid clearance and mitigates neurodegeneration in murine Alzheimer\u2019s disease (vol 178, 536.e1, 2019). Cell. 2020;183:1733\u20134.","journal-title":"Cell"},{"key":"2243_CR51","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1158\/2159-8290.CD-14-0363","volume":"4","author":"G Karsli-Uzunbas","year":"2014","unstructured":"Karsli-Uzunbas G, Guo JY, Price S, Teng X, Laddha SV, Khor S, Kalaany NY, Jacks T, Chan CS, Rabinowitz JD, White E. Autophagy is required for glucose homeostasis and lung tumor maintenance. Cancer Discov. 2014;4:914\u201327.","journal-title":"Cancer Discov"},{"key":"2243_CR52","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.trecan.2021.05.003","volume":"7","author":"E White","year":"2021","unstructured":"White E, Lattime EC, Guo JY. Autophagy regulates stress responses, metabolism, and anticancer immunity. Trends Cancer. 2021;7:778\u201389.","journal-title":"Trends Cancer"},{"key":"2243_CR53","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3390\/life11090903","volume":"11","author":"EJ Lee","year":"2021","unstructured":"Lee EJ, Kim HJ, Choi MS, Chang JE. Crosstalk between autophagy and inflammatory processes in cancer. Life-Basel. 2021;11:903.","journal-title":"Life-Basel"},{"key":"2243_CR54","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.1038\/s41467-019-13475-w","volume":"10","author":"C Quach","year":"2019","unstructured":"Quach C, Song Y, Guo HR, Li S, Maazi H, Fung M, Sands N, O\u2019Connell D, Restrepo-Vassalli S, Chai B, Nemecio D, Punj V, Akbari O, Idos GE, Mumenthaler SM, Wu N, Martin SE, Hagiya A, Hicks J, Cui HM, Liang CY. A truncating mutation in the autophagy gene drives inflammation and tumorigenesis in mice. Nat Commun. 2019;10:5681.","journal-title":"Nat Commun"},{"key":"2243_CR55","doi-asserted-by":"publisher","first-page":"429-+","DOI":"10.1016\/j.molcel.2018.11.018","volume":"73","author":"S Mehto","year":"2019","unstructured":"Mehto S, Jena KK, Nath P, Chauhan S, Kolapalli SP, Das SK, Sahoo PK, Jain A, Taylor GA, Chauhan S. The Crohn\u2019s disease risk factor IRGM limits NLRP3 inflammasome activation by impeding its assembly and by mediating its selective autophagy. Mol Cell. 2019;73:429-+.","journal-title":"Mol Cell"},{"key":"2243_CR56","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.canlet.2017.11.003","volume":"414","author":"LL Wang","year":"2018","unstructured":"Wang LL, Jin XH, Cai MY, Li HG, Chen JW, Wang FW, Wang CY, Hu WW, Liu F, Xie D. AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma. Cancer Lett. 2018;414:71\u201380.","journal-title":"Cancer Lett"},{"key":"2243_CR57","doi-asserted-by":"publisher","first-page":"30094","DOI":"10.1074\/jbc.M113.494286","volume":"288","author":"SL Li","year":"2013","unstructured":"Li SL, Du LL, Zhang L, Hu Y, Xia WC, Wu J, Zhu J, Chen LL, Zhu FQ, Li CX, Yang SJ. Cathepsin B contributes to autophagy-related 7 (Atg7)-induced nod-like receptor 3 (NLRP3)-dependent proinflammatory response and aggravates lipotoxicity in rat insulinoma cell line. J Biol Chem. 2013;288:30094\u2013104.","journal-title":"J Biol Chem"},{"key":"2243_CR58","doi-asserted-by":"publisher","first-page":"441-+","DOI":"10.1016\/j.devcel.2018.07.012","volume":"46","author":"CF Li","year":"2018","unstructured":"Li CF, Zhang Y, Cheng X, Yuan H, Zhu S, Liu J, Wen QR, Xie YC, Liu JB, Kroemer G, Klionsky DJ, Lotze MT, Zeh HJ, Kang R, Tang DL. PINK1 and PARK2 suppress pancreatic tumorigenesis through control of mitochondrial iron-mediated immunometabolism. Dev Cell. 2018;46:441-+.","journal-title":"Dev Cell"},{"key":"2243_CR59","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/hep.30191","volume":"69","author":"WH Li","year":"2019","unstructured":"Li WH, Li YJ, Siraj S, Jin HJ, Fan YY, Yang XR, Huang XW, Wang XH, Wang J, Liu L, Du L, Chen Q. FUN14 domain-containing 1-mediated mitophagy suppresses hepatocarcinogenesis by inhibition of inflammasome activation in mice. Hepatology. 2019;69:604\u201321.","journal-title":"Hepatology"},{"key":"2243_CR60","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1126\/science.1067100","volume":"295","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Fingleton B, Matrisian LM. Cancer therapy - Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 2002;295:2387\u201392.","journal-title":"Science"},{"key":"2243_CR61","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/bjc.2014.271","volume":"111","author":"L Alfonso","year":"2014","unstructured":"Alfonso L, Ai G, Spitale RC, Bhat GJ. Molecular targets of aspirin and cancer prevention. Br J Cancer. 2014;111:61\u20137.","journal-title":"Br J Cancer"},{"key":"2243_CR62","first-page":"1","volume":"20","author":"XB Wang","year":"2020","unstructured":"Wang XB, Ye XX, Zhang YL, Ji F. Flurbiprofen suppresses the inflammation, proliferation, invasion and migration of colorectal cancer cells via COX2. Oncol Lett. 2020;20:1.","journal-title":"Oncol Lett"},{"key":"2243_CR63","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1039\/D4MD00058G","volume":"15","author":"B Cui","year":"2024","unstructured":"Cui B, Cheng XD, Zhang X, Chen LL, Pang WQ, Liu Y, Yang Z, Li H, He XR, Li XL, Bi XL. Anti-cancer activity and mechanism of flurbiprofen organoselenium compound RY-1-92 in non-small cell lung cancer. Rsc Med Chem. 2024;15:1737\u201345.","journal-title":"Rsc Med Chem"},{"key":"2243_CR64","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1056\/NEJMoa1207756","volume":"367","author":"XY Liao","year":"2012","unstructured":"Liao XY, Lochhead P, Nishihara R, Morikawa T, Kuchiba A, Yamauchi M, Imamura Y, Qian ZR, Baba Y, Shima K, Sun RF, Nosho K, Meyerhardt JA, Giovannucci E, Fuchs CS, Chan AT, Ogino S. Aspirin use, tumor mutation, and colorectal-cancer survival. New Engl J Med. 2012;367:1596\u2013606.","journal-title":"New Engl J Med"},{"key":"2243_CR65","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.trecan.2021.11.010","volume":"8","author":"M Kiely","year":"2022","unstructured":"Kiely M, Lord B, Ambs S. Immune response and inflammation in cancer health disparities. Trends Cancer. 2022;8:316\u201327.","journal-title":"Trends Cancer"},{"key":"2243_CR66","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","volume":"27","author":"SL Topalian","year":"2015","unstructured":"Topalian SL, Drake CG, Pardoll DM. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell. 2015;27:450\u201361.","journal-title":"Cancer Cell"},{"key":"2243_CR67","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature10673","volume":"480","author":"I Mellman","year":"2011","unstructured":"Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age. Nature. 2011;480:480\u20139.","journal-title":"Nature"},{"key":"2243_CR68","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","volume":"161","author":"P Sharma","year":"2015","unstructured":"Sharma P, Allison JP. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell. 2015;161:205\u201314.","journal-title":"Cell"},{"key":"2243_CR69","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. 2017;541:321\u201330.","journal-title":"Nature"},{"key":"2243_CR70","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41586-024-07962-4","volume":"634","author":"B Feng","year":"2024","unstructured":"Feng B, Bai Z, Zhou X, Zhao Y, Xie Y-Q, Huang X, Liu Y, Enbar T, Li R, Wang Y, Gao M, Bonati L, Peng M-W, Li W, Tao B, Charmoy M, Held W, Melenhorst JJ, Fan R, Guo Y, Tang L. The type 2 cytokine Fc\u2013IL-4 revitalizes exhausted CD8+ T cells against cancer. Nature. 2024;634:712\u201320.","journal-title":"Nature"},{"key":"2243_CR71","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41574-018-0126-x","volume":"15","author":"DF Quail","year":"2019","unstructured":"Quail DF, Dannenberg AJ. The obese adipose tissue microenvironment in cancer development and progression. Nat Rev Endocrinol. 2019;15:139\u201354.","journal-title":"Nat Rev Endocrinol"},{"key":"2243_CR72","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10549-011-1646-4","volume":"130","author":"RA Mukhtar","year":"2011","unstructured":"Mukhtar RA, Moore AP, Nseyo O, Baehner FL, Au A, Moore DH, Twomey P, Campbell MJ, Esserman LJ. Elevated PCNA plus tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity. Breast Cancer Res Treat. 2011;130:635\u201344.","journal-title":"Breast Cancer Res Treat"},{"key":"2243_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-016-2204-6","volume":"16","author":"RT Sawe","year":"2016","unstructured":"Sawe RT, Kerper M, Badve S, Li J, Sandoval-Cooper M, Xie JM, Shi ZG, Patel K, Chumba D, Ofulla A, Prosperi J, Taylor K, Stack MS, Mining S, Littlepage LE. Aggressive breast cancer in western Kenya has early onset, high proliferation, and immune cell infiltration. BMC Cancer. 2016;16:1.","journal-title":"BMC Cancer"},{"key":"2243_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-020-01297-4","volume":"22","author":"Y Abdou","year":"2020","unstructured":"Abdou Y, Attwood K, Cheng TYD, Yao S, Bandera EV, Zirpoli GR, Ondracek RP, Stein L, Bshara W, Khoury T, Ambrosone CB, Omilian AR. Racial differences in CD8 T cell infiltration in breast tumors from black and white women. Breast Cancer Res. 2020;22:1.","journal-title":"Breast Cancer Res"},{"key":"2243_CR75","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1158\/1055-9965.EPI-18-0955","volume":"28","author":"BD Jenkins","year":"2019","unstructured":"Jenkins BD, Martini RN, Hire R, Brown A, Bennett B, Brown I, Howerth EW, Egan M, Hodgson J, Yates C, Kittles R, Chitale D, Ali H, Nathanson D, Nikolinakos P, Newman L, Monteil M, Davis MB. Atypical chemokine receptor 1 (\/) in breast tumors is associated with survival, circulating chemokines, tumor-infiltrating immune cells, and African ancestry. Cancer Epidem Biomar. 2019;28:690\u2013700.","journal-title":"Cancer Epidem Biomar"},{"key":"2243_CR76","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41523-021-00215-x","volume":"7","author":"J Roelands","year":"2021","unstructured":"Roelands J, Mall R, Almeer H, Thomas R, Mohamed MG, Bedri S, Al-Bader SB, Junejo K, Ziv E, Sayaman RW, Kuppen PJK, Bedognetti D, Hendrickx W, Decock J. Ancestry-associated transcriptomic profiles of breast cancer in patients of African, Arab, and European ancestry. Npj Breast Cancer. 2021;7:10.","journal-title":"Npj Breast Cancer"},{"key":"2243_CR77","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1038\/s41467-020-17414-y","volume":"11","author":"M Terranova-Barberio","year":"2020","unstructured":"Terranova-Barberio M, Pawlowska N, Dhawan M, Moasser M, Chien AJ, Melisko ME, Rugo H, Rahimi R, Deal T, Daud A, Rosenblum MD, Thomas S, Munster PN. Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer. Nat Commun. 2020;11:3584.","journal-title":"Nat Commun"},{"key":"2243_CR78","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1093\/annonc\/mdu191","volume":"25","author":"HR Ali","year":"2014","unstructured":"Ali HR, Provenzano E, Dawson SJ, Blows FM, Liu B, Shah M, Earl HM, Poole CJ, Hiller L, Dunn JA, Bowden SJ, Twelves C, Bartlett JMS, Mahmoud SMA, Rakha E, Ellis IO, Liu S, Gao D, Nielsen TO, Pharoah PDP, Caldas C. Association between CD8+T-cell infiltration and breast cancer survival in 12 439 patients. Ann Oncol. 2014;25:1536\u201343.","journal-title":"Ann Oncol"},{"key":"2243_CR79","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1200\/JCO.2014.58.1967","volume":"33","author":"C Denkert","year":"2015","unstructured":"Denkert C, von Minckwitz G, Brase JC, Sinn BV, Gade S, Kronenwett R, Pfitzner BM, Salat C, Loi S, Schmitt WD, Schem C, Fisch K, Darb-Esfahani S, Mehta K, Sotiriou C, Wienert S, Klare P, Andr\u00e9 F, Klauschen F, Blohmer JU, Krappmann K, Schmidt M, Tesch H, K\u00fcmmel S, Sinn P, Jackisch C, Dietel M, Reimer T, Untch M, Loibl S. Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers. J Clin Oncol. 2015;33:983\u201391.","journal-title":"J Clin Oncol"},{"key":"2243_CR80","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41568-020-0267-9","volume":"20","author":"JS de Bono","year":"2020","unstructured":"de Bono JS, Guo C, Gurel B, De Marzo AM, Sfanos KS, Mani RS, Gil J, Drake CG, Alimonti A. Prostate carcinogenesis: inflammatory storms. Nat Rev Cancer. 2020;20:455\u201369.","journal-title":"Nat Rev Cancer"},{"issue":"111","key":"2243_CR81","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/jnci\/djy141","volume":"I","author":"SG Zhao","year":"2019","unstructured":"Zhao SG, Lehrer J, Chang SL, Das R, Erho N, Liu Y, Sj\u00f6str\u00f6m M, Den RB, Freedland SJ, Klein EA, Karnes RJ, Schaeffer EM, Xu M, Speers C, Nguyen PL, Ross AE, Chan JM, Cooperberg MR, Carroll PR, Davicioni E, Fong L, Spratt DE, Feng FY. The immune landscape of prostate cancer and nomination of PD-L2 as a potential therapeutic target. Jnci-J Natl Cancer. 2019;I(111):301\u201310.","journal-title":"Jnci-J Natl Cancer"},{"key":"2243_CR82","doi-asserted-by":"publisher","first-page":"363-+","DOI":"10.1038\/s41586-018-0266-0","volume":"559","author":"A Calcinotto","year":"2018","unstructured":"Calcinotto A, Spataro C, Zagato E, Di Mitri D, Gil V, Crespo M, De Bernardis G, Losa M, Mirenda M, Pasquini E, Rinaldi A, Sumanasuriya S, Lambros MB, Neeb A, Lucian\u00f2 R, Bravi CA, Nava-Rodrigues D, Dolling D, Prayer-Galetti T, Ferreira A, Briganti A, Esposito A, Barry S, Yuan W, Sharp A, de Bono J, Alimonti A. IL-23 secreted by myeloid cells drives castration-resistant prostate cancer. Nature. 2018;559:363-+.","journal-title":"Nature"},{"key":"2243_CR83","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1158\/1541-7786.MCR-19-0595","volume":"18","author":"JP Maynard","year":"2020","unstructured":"Maynard JP, Ertunc O, Kulac I, Baena-Del Valle JA, De Marzo AM, Sfanos KS. IL8 expression is associated with prostate cancer aggressiveness and androgen receptor loss in primary and metastatic prostate cancer. Mol Cancer Res. 2020;18:153\u201365.","journal-title":"Mol Cancer Res"},{"key":"2243_CR84","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3390\/cancers12071716","volume":"12","author":"C Buigues","year":"2020","unstructured":"Buigues C, Navarro-Mart\u00ednez R, S\u00e1nchez-Mart\u00ednez V, Serrano-Carrascosa M, Rubio-Briones J, Cauli O. Interleukin-6 and lymphocyte count associated and predicted the progression of frailty syndrome in prostate cancer patients undergoing antiandrogen therapy. Cancers. 2020;12:1716.","journal-title":"Cancers"},{"key":"2243_CR85","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/cjp2.160","volume":"6","author":"JL Wen","year":"2020","unstructured":"Wen JL, Huang G, Liu S, Wan J, Wang XC, Zhu YN, Kaliney W, Zhang C, Cheng L, Wen XF, Lu X. Polymorphonuclear MDSCs are enriched in the stroma and expanded in metastases of prostate cancer. J Pathol Clin Res. 2020;6:171\u20137.","journal-title":"J Pathol Clin Res"},{"key":"2243_CR86","doi-asserted-by":"publisher","first-page":"6134","DOI":"10.1158\/0008-5472.CAN-17-3810","volume":"78","author":"M Gillard","year":"2018","unstructured":"Gillard M, Javier R, Ji Y, Zheng SL, Xu J, Brendler CB, Crawford SE, Pierce BL, Griend DJ, Franco OE. Elevation of stromal-derived mediators of inflammation promote prostate cancer progression in African-American men. Cancer Res. 2018;78:6134\u201345.","journal-title":"Cancer Res"},{"key":"2243_CR87","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41423-021-00742-4","volume":"19","author":"LA Huppert","year":"2022","unstructured":"Huppert LA, Green MD, Kim L, Chow C, Leyfman Y, Daud AI, Lee JC. Tissue-specific tregs in cancer metastasis: opportunities for precision immunotherapy. Cell Mol Immunol. 2022;19:33\u201345.","journal-title":"Cell Mol Immunol"},{"key":"2243_CR88","doi-asserted-by":"publisher","first-page":"1353-+","DOI":"10.1126\/science.aao4227","volume":"361","author":"J Albrengues","year":"2018","unstructured":"Albrengues J, Shields MA, Ng D, Park CG, Ambrico A, Poindexter ME, Upadhyay P, Uyeminami DL, Pommier A, Kuttner V, Bruzas E, Maiorino L, Bautista C, Carmona EM, Gimotty PA, Fearon DT, Chang K, Lyons SK, Pinkerton KE, Trotman LC, Goldberg MS, Yeh JTH, Egeblad M. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science. 2018;361:1353-+.","journal-title":"Science"},{"key":"2243_CR89","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1038\/s41467-018-06268-0","volume":"9","author":"CC Lee","year":"2018","unstructured":"Lee CC, Lin JC, Hwang WL, Kuo YJ, Chen HK, Tai SK, Lin CC, Yang MH. Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonization. Nat Commun. 2018;9:3763.","journal-title":"Nat Commun"},{"key":"2243_CR90","doi-asserted-by":"publisher","first-page":"659036","DOI":"10.3389\/fonc.2021.659036","volume":"11","author":"K Wallace","year":"2021","unstructured":"Wallace K, Nahhas GJ, Bookhout C, Lewin DN, Paulos CM, Nikolaishvili-Feinberg N, Cohen SM, Guglietta S, Bakhtiari A, Camp ER, Hill EG, Baron JA, Wu JD, Alekseyenko AV. Preinvasive colorectal lesions of African Americans display an immunosuppressive signature compared to Caucasian Americans. Front Oncol. 2021;11:659036.","journal-title":"Front Oncol"},{"key":"2243_CR91","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1158\/1055-9965.EPI-18-0598","volume":"28","author":"D Brown","year":"2019","unstructured":"Brown D, Zingone A, Yu YK, Zhu B, Candia J, Cao L, Ryan BM. Relationship between circulating inflammation proteins and lung cancer diagnosis in the national lung screening trial. Cancer Epidem Biomar. 2019;28:110\u20138.","journal-title":"Cancer Epidem Biomar"},{"key":"2243_CR92","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.jtho.2019.03.014","volume":"14","author":"CL Meaney","year":"2019","unstructured":"Meaney CL, Mitchell KA, Zingone A, Brown D, Bowman E, Yu YK, Wenzlaff AS, Neslund-Dudas C, Pine SR, Cao L, Schwartz AG, Ryan BM. Circulating inflammation proteins associated with lung cancer in African Americans. J Thorac Oncol. 2019;14:1192\u2013203.","journal-title":"J Thorac Oncol"},{"key":"2243_CR93","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1002\/cam4.3753","volume":"10","author":"T Curran","year":"2021","unstructured":"Curran T, Sun ZQ, Gerry B, Findlay VJ, Wallace K, Li ZH, Paulos C, Ford M, Rubinstein MP, Chung DJ, Camp ER. Differential immune signatures in the tumor microenvironment are associated with colon cancer racial disparities. Cancer Med. 2021;10:1805\u201314.","journal-title":"Cancer Med"},{"key":"2243_CR94","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.cell.2021.02.011","volume":"184","author":"M Dougan","year":"2021","unstructured":"Dougan M, Luoma AM, Dougan SK, Wucherpfennig KW. Understanding and treating the inflammatory adverse events of cancer immunotherapy. Cell. 2021;184:1575\u201388.","journal-title":"Cell"},{"key":"2243_CR95","doi-asserted-by":"publisher","first-page":"e145186","DOI":"10.1172\/JCI145186","volume":"131","author":"J Moslehi","year":"2021","unstructured":"Moslehi J, Lichtman AH, Sharpe AH, Galluzzi L, Kitsis RN. Immune checkpoint inhibitor-associated myocarditis: manifestations arms mechanisms. J Clin Invest. 2021;131:e145186.","journal-title":"J Clin Invest"},{"key":"2243_CR96","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1161\/CIRCRESAHA.124.324260","volume":"135","author":"LL Lou","year":"2024","unstructured":"Lou LL, Detering L, Luehmann H, Amrute JM, Sultan D, Ma P, Li A, Lahad D, Bredemeyer A, Zhang XL, Heo GS, Lavine K, Liu YJ. Visualizing immune checkpoint inhibitors derived inflammation in atherosclerosis. Circ Res. 2024;135:990\u20131003.","journal-title":"Circ Res"},{"key":"2243_CR97","doi-asserted-by":"publisher","first-page":"7316","DOI":"10.1038\/s41467-022-35096-6","volume":"13","author":"QQ Sui","year":"2022","unstructured":"Sui QQ, Zhang X, Chen C, Tang JH, Yu JH, Li WH, Han K, Jiang W, Liao LE, Kong LH, Li Y, Hou ZL, Zhou C, Zhang CZ, Zhang LJ, Xiao BY, Mei WJ, Xu YB, Qin JY, Zheng J, Pan ZZ, Ding PR. Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer. Nat Commun. 2022;13:7316.","journal-title":"Nat Commun"},{"key":"2243_CR98","doi-asserted-by":"publisher","first-page":"655-+","DOI":"10.1016\/j.cell.2020.06.001","volume":"182","author":"AM Luoma","year":"2020","unstructured":"Luoma AM, Suo SB, Williams HL, Sharova T, Sullivan K, Manos M, Bowling P, Hodi FS, Rahma O, Sullivan RJ, Boland GM, Nowak JA, Dougan SK, Dougan M, Yuan GC, Wucherpfennig KW. Molecular pathways of colon inflammation induced by cancer immunotherapy. Cell. 2020;182:655-+.","journal-title":"Cell"},{"key":"2243_CR99","doi-asserted-by":"publisher","first-page":"e005841","DOI":"10.1136\/jitc-2022-005841","volume":"11","author":"LL Liu","year":"2023","unstructured":"Liu LL, Skribek M, Harmenberg U, Gerling M. Systemic inflammatory syndromes as life-threatening side effects of immune checkpoint inhibitors: case report and systematic review of the literature. J Immunother Cancer. 2023;11:e005841.","journal-title":"J Immunother Cancer"},{"key":"2243_CR100","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nri3793","volume":"15","author":"AR Tall","year":"2015","unstructured":"Tall AR, Yvan-Charvet L. Cholesterol, inflammation and innate immunity. Nat Rev Immunol. 2015;15:104\u201316.","journal-title":"Nat Rev Immunol"},{"key":"2243_CR101","doi-asserted-by":"publisher","first-page":"154338","DOI":"10.1016\/j.metabol.2020.154338","volume":"114","author":"A Christofides","year":"2021","unstructured":"Christofides A, Konstantinidou E, Jani C, Boussiotis VA. The role of peroxisome proliferator-activated receptors (PPAR) in immune responses. Metab-Clin Exp. 2021;114:154338.","journal-title":"Metab-Clin Exp"},{"key":"2243_CR102","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.pharmthera.2005.08.007","volume":"110","author":"LA Moraes","year":"2006","unstructured":"Moraes LA, Piqueras L, Bishop-Bailey D. Peroxisome proliferator-activated receptors and inflammation. Pharmacol Ther. 2006;110:371\u201385.","journal-title":"Pharmacol Ther"},{"key":"2243_CR103","doi-asserted-by":"publisher","first-page":"25573","DOI":"10.1074\/jbc.273.40.25573","volume":"273","author":"G Chinetti","year":"1998","unstructured":"Chinetti G, Griglio S, Antonucci M, Torra IP, Delerive P, Majd Z, Fruchart JC, Chapman J, Najib J, Staels B. Activation of proliferator-activated receptors \u03b1 and \u03b3 induces apoptosis of human monocyte-derived macrophages. J Biol Chem. 1998;273:25573\u201380.","journal-title":"J Biol Chem"},{"key":"2243_CR104","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1002\/med.21970","volume":"43","author":"YJ Pu","year":"2023","unstructured":"Pu YJ, Cheng CK, Zhang HS, Luo JY, Wang L, Tomlinson B, Huang Y. Molecular mechanisms and therapeutic perspectives of peroxisome proliferator-activated receptor \u03b1 agonists in cardiovascular health and disease. Med Res Rev. 2023;43:2086\u2013114.","journal-title":"Med Res Rev"},{"key":"2243_CR105","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.2174\/1389450120666190405172524","volume":"20","author":"SK Wong","year":"2019","unstructured":"Wong SK, Chin K-Y, Ima-Nirwana S. Toll-like receptor as a molecular link between metabolic syndrome and inflammation: a review. Curr Drug Targets. 2019;20:1264\u201380.","journal-title":"Curr Drug Targets"},{"key":"2243_CR106","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1053\/j.gastro.2019.05.057","volume":"157","author":"Y Luo","year":"2019","unstructured":"Luo Y, Xie C, Brocker CN, Fan J, Wu X, Feng L, Wang Q, Zhao J, Lu D, Tandon M, Cam M, Krausz KW, Liu W, Gonzalez FJ. Intestinal PPAR\u03b1 protects against colon carcinogenesis via regulation of methyltransferases DNMT1 and PRMT6. Gastroenterology. 2019;157:744-759.e744.","journal-title":"Gastroenterology"},{"key":"2243_CR107","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.cmet.2024.04.015","volume":"36","author":"S Gallage","year":"2024","unstructured":"Gallage S, Ali A, Avila JEB, Seymen N, Ramadori P, Joerke V, Zizmare L, Aicher D, Gopalsamy IK, Fong W, Kosla J, Focaccia E, Li X, Yousuf S, Sijmonsma T, Rahbari M, Kommoss KS, Billeter A, Prokosch S, Rothermel U, Mueller F, Hetzer J, Heide D, Schinkel B, Machauer T, Pichler B, Malek NP, Longerich T, Roth S, Rose AJ, Schwenck J, Trautwein C, Karimi MM, Heikenwalder M. A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPAR a and PCK1. Cell Metab. 2024;36:1371.","journal-title":"Cell Metab"},{"key":"2243_CR108","doi-asserted-by":"publisher","first-page":"876418","DOI":"10.1155\/2012\/876418","volume":"2012","author":"JI Park","year":"2012","unstructured":"Park JI, Kwak JY. The role of peroxisome proliferator-activated receptors in colorectal cancer. PPAR Res. 2012;2012:876418.","journal-title":"PPAR Res"},{"key":"2243_CR109","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41388-023-02914-0","volume":"43","author":"SS Chauhan","year":"2024","unstructured":"Chauhan SS, Casillas AL, Vizzerra AD, Liou H, Clements AN, Flores CE, Prevost CT, Kashatus DF, Snider AJ, Snider JM, Warfel NA. PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancer. Oncogene. 2024;43:406\u201319.","journal-title":"Oncogene"},{"key":"2243_CR110","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1126\/science.289.5483.1357","volume":"289","author":"TG Kroll","year":"2000","unstructured":"Kroll TG. PAX8-PPAR\u03b31 fusion oncogene in human thyroid carcinoma (vol 289, pg 1357, 2000). Science. 2000;289:1474\u20131474.","journal-title":"Science"},{"key":"2243_CR111","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1016\/j.febslet.2011.10.021","volume":"585","author":"JL Tong","year":"2011","unstructured":"Tong JL, Zhang CP, Nie F, Xu XT, Zhu MM, Xiao SD, Ran ZH. MicroRNA 506 regulates expression of PPAR alpha in hydroxycamptothecin-resistant human colon cancer cells. FEBS Lett. 2011;585:3560\u20138.","journal-title":"FEBS Lett"},{"key":"2243_CR112","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s10620-018-5424-6","volume":"64","author":"JW Liu","year":"2019","unstructured":"Liu JW, Li H, Sun LP, Shen SX, Zhou Q, Yuan Y, Xing CZ. Epigenetic alternations of MicroRNAs and DNA methylation contribute to liver metastasis of colorectal cancer. Dig Dis Sci. 2019;64:1523\u201334.","journal-title":"Dig Dis Sci"},{"key":"2243_CR113","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1038\/s41467-022-32101-w","volume":"13","author":"YY Tan","year":"2022","unstructured":"Tan YY, Li JJ, Zhao GY, Huang KC, Cardenas H, Wang YN, Matei D, Cheng JX. Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells. Nat Commun. 2022;13:4554.","journal-title":"Nat Commun"},{"key":"2243_CR114","doi-asserted-by":"publisher","first-page":"e163624","DOI":"10.1172\/jci.insight.163624","volume":"8","author":"G Li","year":"2023","unstructured":"Li G, Li X, Mahmud I, Ysaguirre J, Fekry B, Wang SY, Wei B, Eckel-Mahan KL, Lorenzi PL, Lehner R, Sun K. Interfering with lipid metabolism through targeting CES1 sensitizes hepatocellular carcinoma for chemotherapy. Jci Insight. 2023;8:e163624.","journal-title":"Jci Insight"},{"key":"2243_CR115","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/carcin\/bgx035","volume":"38","author":"W Zhang","year":"2017","unstructured":"Zhang W, Xu Y, Xu Q, Shi H, Shi J, Hou Y. PPAR\u03b4 promotes tumor progression via activation of Glut1 and SLC1-A5 transcription. Carcinogenesis. 2017;38:748\u201355.","journal-title":"Carcinogenesis"},{"key":"2243_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2023.13899","volume":"26","author":"M Kogami","year":"2023","unstructured":"Kogami M, Abe S, Nakamura H, Aoshiba K. Fenofibrate attenuates the cytotoxic effect of cisplatin on lung cancer cells by enhancing the antioxidant defense system. Oncol Lett. 2023;26:1.","journal-title":"Oncol Lett"},{"key":"2243_CR117","first-page":"427","volume":"70","author":"H Kato","year":"2018","unstructured":"Kato H, Perl A. Blockade of Treg cell differentiation and function by the interleukin-21-mechanistic target of rapamycin axis via suppression of autophagy in patients with systemic lupus erythematosus, arthritis. Rheumatol. 2018;70:427\u201338.","journal-title":"Rheumatol"},{"key":"2243_CR118","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/15548627.2015.1009787","volume":"11","author":"K Liu","year":"2015","unstructured":"Liu K, Zhao EP, Ilyas G, Lalazar G, Lin Y, Haseeb M, Tanaka KE, Czaja MJ. Impaired macrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization. Autophagy. 2015;11:271\u201384.","journal-title":"Autophagy"},{"key":"2243_CR119","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.4161\/auto.6.8.13547","volume":"6","author":"S Yoon","year":"2010","unstructured":"Yoon S, Woo SU, Kang JH, Kim K, Kwon MH, Park S, Shin HJ, Gwak HS, Chwae YJ. STAT3 transcriptional factor activated by reactive oxygen species induces IL6 in starvation-induced autophagy of cancer cells. Autophagy. 2010;6:1125\u201338.","journal-title":"Autophagy"},{"key":"2243_CR120","doi-asserted-by":"publisher","first-page":"e24705","DOI":"10.1371\/journal.pone.0024705","volume":"6","author":"J Yan","year":"2011","unstructured":"Yan J, Wang ZY, Yang HZ, Liu HZ, Mi S, Lv XX, Fu XM, Yan HM, Zhang XW, Zhan QM, Hu ZW. Timing is critical for an effective anti-metastatic immunotherapy: the decisive role of IFN\u03b3\/STAT1-mediated activation of autophagy. PloS one. 2011;6:e24705.","journal-title":"PloS one"},{"key":"2243_CR121","doi-asserted-by":"publisher","first-page":"e1375640","DOI":"10.1080\/2162402X.2017.1375640","volume":"7","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Guo QL, Zhao K, Zhou YX, Li WJ, Pan CY, Qiang L, Li ZY, Lu N. Small molecule GL-V9 protects against colitis-associated colorectal cancer by limiting NLRP3 inflammasome through autophagy. Oncoimmunology. 2018;7:e1375640.","journal-title":"Oncoimmunology"},{"key":"2243_CR122","doi-asserted-by":"crossref","unstructured":"Wu HY, Yang FL, Li LH, Rao YK, Ju TC, Wong WT, Hsieh CY, Pivkin MV, Hua KF, Wu SH. Ergosterol peroxide from marine fungus. induces ROS-dependent apoptosis and autophagy in human lung adenocarcinoma cells. Sci Rep. 2018;8:17956.","DOI":"10.1038\/s41598-018-36411-2"},{"key":"2243_CR123","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.semcancer.2020.01.002","volume":"65","author":"MM Wattenberg","year":"2020","unstructured":"Wattenberg MM, Beatty GL. Overcoming immunotherapeutic resistance by targeting the cancer inflammation cycle. Semin Cancer Biol. 2020;65:38\u201350.","journal-title":"Semin Cancer Biol"},{"key":"2243_CR124","doi-asserted-by":"publisher","first-page":"115015","DOI":"10.1016\/j.biopha.2023.115015","volume":"164","author":"M Nigam","year":"2023","unstructured":"Nigam M, Mishra AP, Deb VK, Dimri DB, Tiwari V, Bungau SG, Bungau AF, Radu AF. Evaluation of the association of chronic inflammation and cancer: insights and implications. Biomed Pharmacother. 2023;164:115015.","journal-title":"Biomed Pharmacother"},{"key":"2243_CR125","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/j.freeradbiomed.2012.02.035","volume":"52","author":"JK Kundu","year":"2012","unstructured":"Kundu JK, Surh YJ. Emerging avenues linking inflammation and cancer. Free Radical Bio Med. 2012;52:2013\u201337.","journal-title":"Free Radical Bio Med"},{"key":"2243_CR126","first-page":"176","volume":"4","author":"YH Fan","year":"2013","unstructured":"Fan YH, Mao RF, Yang JH. NF-\u03baB and STAT3 signaling pathways collaboratively link inflammation to cancer, Protein. Cell. 2013;4:176\u201385.","journal-title":"Cell"},{"key":"2243_CR127","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1158\/2159-8290.CD-22-1220","volume":"13","author":"V Klapp","year":"2023","unstructured":"Klapp V, \u00c1lvarez-Abril B, Leuzzi G, Kroemer G, Ciccia A, Galluzzi L. The DNA damage response and inflammation in cancer. Cancer Discov. 2023;13:1521\u201345.","journal-title":"Cancer Discov"},{"key":"2243_CR128","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1084\/jem.20180139","volume":"215","author":"T Li","year":"2018","unstructured":"Li T, Chen ZJJ. The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer. J Exp Med. 2018;215:1287\u201399.","journal-title":"J Exp Med"},{"key":"2243_CR129","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nrc1046","volume":"3","author":"SP Hussain","year":"2003","unstructured":"Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer. 2003;3:276\u201385.","journal-title":"Nat Rev Cancer"},{"key":"2243_CR130","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mrfmmm.2005.04.013","volume":"591","author":"H Bartsch","year":"2005","unstructured":"Bartsch H, Nair J. Accumulation of lipid peroxidation-derived DNA lesions: potential lead markers for chemoprevention of inflammation-driven malignancies. Mutat Res-Fund Mol M. 2005;591:34\u201344.","journal-title":"Mutat Res-Fund Mol M"},{"key":"2243_CR131","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","volume":"30","author":"F Colotta","year":"2009","unstructured":"Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009;30:1073\u201381.","journal-title":"Carcinogenesis"},{"key":"2243_CR132","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nrm2858","volume":"11","author":"S Negrini","year":"2010","unstructured":"Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability - an evolving hallmark of cancer. Nat Rev Mol Cell Bio. 2010;11:220\u20138.","journal-title":"Nat Rev Mol Cell Bio"},{"key":"2243_CR133","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"2243_CR134","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/path.1409","volume":"201","author":"L Kruidenier","year":"2003","unstructured":"Kruidenier L, Kulper I, Lamers CBHW, Verspaget HW. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol. 2003;201:28\u201336.","journal-title":"J Pathol"},{"key":"2243_CR135","first-page":"3333","volume":"60","author":"SP Hussain","year":"2000","unstructured":"Hussain SP, Amstad P, Raja K, Ambs S, Nagashima M, Bennett WP, Shields PG, Ham AJ, Swenberg JA, Marrogi AJ, Harris CC. Increased mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Can Res. 2000;60:3333\u20137.","journal-title":"Can Res"},{"key":"2243_CR136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10937400701436460","volume":"11","author":"N Azad","year":"2008","unstructured":"Azad N, Rojanasakul Y, Vallyathan V. Inflammation and lung cancer: roles of reactive oxygen\/nitrogen species. J Toxicol Env Heal B. 2008;11:1\u201315.","journal-title":"J Toxicol Env Heal B"},{"key":"2243_CR137","first-page":"2516","volume":"118","author":"LB Meira","year":"2008","unstructured":"Meira LB, Bugni JM, Green SL, Lee CW, Pang B, Borenshtein D, Rickman BH, Rogers AB, Moroski-Erkul CA, McFaline JL, Schauer DB, Dedon PC, Fox JG, Samson LD. DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Investig. 2008;118:2516\u201325.","journal-title":"J Clin Investig"},{"key":"2243_CR138","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1038\/onc.2012.451","volume":"32","author":"HX Yan","year":"2013","unstructured":"Yan HX, Wu HP, Zhang HL, Ashton C, Tong C, Wu J, Qian QJ, Wang HY, Ying QL. DNA damage-induced sustained p53 activation contributes to inflammation-associated hepatocarcinogenesis in rats. Oncogene. 2013;32:4565\u201371.","journal-title":"Oncogene"},{"key":"2243_CR139","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nature04478","volume":"438","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet P. Angiogenesis in life, disease and medicine. Nature. 2005;438:932\u20136.","journal-title":"Nature"},{"key":"2243_CR140","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35025220","volume":"407","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407:249\u201357.","journal-title":"Nature"},{"key":"2243_CR141","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nm0603-653","volume":"9","author":"P Carmeliet","year":"2003","unstructured":"Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003;9:653\u201360.","journal-title":"Nat Med"},{"key":"2243_CR142","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrd2115","volume":"6","author":"J Folkman","year":"2007","unstructured":"Folkman J. Opinion - Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discovery. 2007;6:273\u201386.","journal-title":"Nat Rev Drug Discovery"},{"key":"2243_CR143","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10456-007-9074-0","volume":"10","author":"C Costa","year":"2007","unstructured":"Costa C, Incio J, Soares R. Angiogenesis and chronic inflammation: cause or consequence? Angiogenesis. 2007;10:149\u201366.","journal-title":"Angiogenesis"},{"key":"2243_CR144","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/367032a0","volume":"367","author":"M Schliwa","year":"1994","unstructured":"Schliwa M. Guidebook to the extracellular-matrix and adhesion proteins - Kreis, T, Vale, R. Nature. 1994;367:32\u201332.","journal-title":"Nature"},{"key":"2243_CR145","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1385\/IR:24:1:87","volume":"24","author":"K Ley","year":"2001","unstructured":"Ley K. Pathways and bottlenecks in the web of inflammatory adhesion molecules and chemoattractants. Immunol Res. 2001;24:87\u201395.","journal-title":"Immunol Res"},{"key":"2243_CR146","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ccr.2005.02.013","volume":"7","author":"F Balkwill","year":"2005","unstructured":"Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell. 2005;7:211\u20137.","journal-title":"Cancer Cell"},{"key":"2243_CR147","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1349-7006.2006.00197.x","volume":"97","author":"A Yoshimura","year":"2006","unstructured":"Yoshimura A. Signal transduction of inflammatory cytokines and tumor development. Cancer Sci. 2006;97:439\u201347.","journal-title":"Cancer Sci"},{"key":"2243_CR148","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10555-006-9005-3","volume":"25","author":"F Balkwill","year":"2006","unstructured":"Balkwill F. TNF-\u03b1 in promotion and progression of cancer. Cancer Metast Rev. 2006;25:409\u201316.","journal-title":"Cancer Metast Rev"},{"key":"2243_CR149","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1161\/01.RES.0000146672.10582.17","volume":"95","author":"IF Charo","year":"2004","unstructured":"Charo IF, Taubman MB. Chemokines in the pathogenesis of vascular disease. Circ Res. 2004;95:858\u201366.","journal-title":"Circ Res"},{"key":"2243_CR150","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0092-8674(00)00139-2","volume":"103","author":"LM Coussens","year":"2000","unstructured":"Coussens LM, Tinkle CL, Hanahan D, Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell. 2000;103:481\u201390.","journal-title":"Cell"},{"key":"2243_CR151","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1136\/jcp.2003.014498","volume":"57","author":"I Esposito","year":"2004","unstructured":"Esposito I, Menicagli M, Funel N, Bergmann F, Boggi U, Mosca F, Bevilacqua G, Campani D. Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J Clin Pathol. 2004;57:630\u20136.","journal-title":"J Clin Pathol"},{"key":"2243_CR152","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/nrc909","volume":"2","author":"N Ferrara","year":"2002","unstructured":"Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer. 2002;2:795\u2013803.","journal-title":"Nat Rev Cancer"},{"key":"2243_CR153","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/70928","volume":"5","author":"N Ferrara","year":"1999","unstructured":"Ferrara N, Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med. 1999;5:1359\u201364.","journal-title":"Nat Med"},{"key":"2243_CR154","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2174\/156802606776287045","volume":"6","author":"QXA Sang","year":"2006","unstructured":"Sang QXA, Jin YH, Newcomer RG, Monroe SC, Fang XX, Hurst DR, Lee S, Cao Q, Schwartz MTA. Matrix metalloproteinase inhibitors as prospective agents for the prevention and treatment of cardiovascular and neoplastic diseases. Curr Top Med Chem. 2006;6:289\u2013316.","journal-title":"Curr Top Med Chem"},{"key":"2243_CR155","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3816\/CCC.2007.n.004","volume":"6","author":"S Wadler","year":"2007","unstructured":"Wadler S. Targeted therapy in colorectal cancer. Clin Colorectal Canc. 2007;6:357\u201361.","journal-title":"Clin Colorectal Canc"},{"key":"2243_CR156","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc1388","volume":"4","author":"F Balkwill","year":"2004","unstructured":"Balkwill F. Cancer and the chemokine network. Nat Rev Cancer. 2004;4:540\u201350.","journal-title":"Nat Rev Cancer"},{"key":"2243_CR157","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/35065016","volume":"410","author":"A M\u00fcller","year":"2001","unstructured":"M\u00fcller A, Homey B, Soto H, Ge NF, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Ver\u00e1stegui E, Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410:50\u20136.","journal-title":"Nature"},{"key":"2243_CR158","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1182\/blood-2005-08-3182","volume":"107","author":"JA Burger","year":"2006","unstructured":"Burger JA, Kipps TJ. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood. 2006;107:1761\u20137.","journal-title":"Blood"},{"key":"2243_CR159","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1093\/jnci\/dji431","volume":"97","author":"JT Kaifi","year":"2005","unstructured":"Kaifi JT, Yekebas EF, Schurr P, Obonyo D, Wachowiak R, Busch P, Heinecke A, Pantel K, Izbicki JR. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. J Natl Cancer Inst. 2005;97:1840\u20137.","journal-title":"J Natl Cancer Inst"},{"key":"2243_CR160","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10549-005-9121-8","volume":"97","author":"O Salvucci","year":"2006","unstructured":"Salvucci O, Bouchard L, Baccarelli A, Desch\u00eanes J, Sauter G, Simon R, Bianchi R, Basik M. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study. Breast Cancer Res Treat. 2006;97:275\u201383.","journal-title":"Breast Cancer Res Treat"},{"key":"2243_CR161","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1200\/JCO.2005.07.078","volume":"23","author":"J Kim","year":"2005","unstructured":"Kim J, Takeuchi H, Lam ST, Turner RR, Wang HJ, Kuo C, Foshag L, Bilchik AJ, Hoon DSB. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol. 2005;23:2744\u201353.","journal-title":"J Clin Oncol"},{"key":"2243_CR162","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ccr.2007.04.020","volume":"11","author":"JD Shields","year":"2007","unstructured":"Shields JD, Fleury ME, Yong C, Tomei AA, Randolph GJ, Swartz MA. Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell. 2007;11:526\u201338.","journal-title":"Cancer Cell"},{"key":"2243_CR163","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1158\/0008-5472.CAN-03-1757","volume":"64","author":"K Kawada","year":"2004","unstructured":"Kawada K, Sonoshita M, Sakashita H, Takabayashi A, Yamaoka Y, Manabe T, Inaba K, Minato N, Oshima M, Taketo MM. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Can Res. 2004;64:4010\u20137.","journal-title":"Can Res"},{"key":"2243_CR164","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1158\/0008-5472.CAN-03-3437","volume":"64","author":"SA Shulby","year":"2004","unstructured":"Shulby SA, Dolloff NG, Stearns ME, Meucci O, Fatatis A. CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells. Can Res. 2004;64:4693\u20138.","journal-title":"Can Res"},{"key":"2243_CR165","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1084\/jem.20052144","volume":"203","author":"JM Burns","year":"2006","unstructured":"Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao ZH, Penfold MET, Sunshine MJ, Littman DR, Kuo CJ, Wei K, McMaster BE, Wright K, Howard MC, Schall TJ. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med. 2006;203:2201\u201313.","journal-title":"J Exp Med"},{"key":"2243_CR166","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1158\/0008-5472.CAN-06-3087","volume":"67","author":"A Zipin-Roitman","year":"2007","unstructured":"Zipin-Roitman A, Meshel T, Sagi-Assif O, Shalmon B, Avivi C, Pfeffer RM, Witz IP, Ben-Baruch A. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells. Can Res. 2007;67:3396\u2013405.","journal-title":"Can Res"},{"key":"2243_CR167","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1200\/JCO.2005.04.1822","volume":"24","author":"P Ghadjar","year":"2006","unstructured":"Ghadjar P, Coupland SE, Na IK, Noutsias M, Letsch A, Stroux A, Batter S, Buhr HJ, Thiel E, Scheibenbogen C, Keilholz U. Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer. J Clin Oncol. 2006;24:1910\u20136.","journal-title":"J Clin Oncol"},{"key":"2243_CR168","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1158\/0008-5472.CAN-06-2941","volume":"67","author":"H Kulbe","year":"2007","unstructured":"Kulbe H, Thompson R, Wilson JL, Robinson S, Hagemann T, Fatah R, Gould D, Ayhan A, Balkwill F. The inflammatory cytokine tumor necrosis factor-\u03b1 generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Can Res. 2007;67:585\u201392.","journal-title":"Can Res"},{"key":"2243_CR169","doi-asserted-by":"publisher","first-page":"10355","DOI":"10.1158\/0008-5472.CAN-05-0957","volume":"65","author":"H Kulbe","year":"2005","unstructured":"Kulbe H, Hagemann T, Szlosarek PW, Balkwill FR, Wilson JL. The inflammatory cytokine tumor necrosis factor-\u03b1 regulates chemokine receptor expression on ovarian cancer cells. Can Res. 2005;65:10355\u201362.","journal-title":"Can Res"},{"key":"2243_CR170","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1091\/mbc.e02-09-0583","volume":"14","author":"RC Bates","year":"2003","unstructured":"Bates RC, Mercurio AM. Tumor necrosis factor-\u03b1 stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol Biol Cell. 2003;14:1790\u2013800.","journal-title":"Mol Biol Cell"},{"key":"2243_CR171","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41523-021-00376-9","volume":"8","author":"JA Sparano","year":"2022","unstructured":"Sparano JA, O\u2019Neill A, Graham N, Northfelt DW, Dang CT, Wolff AC, Sledge GW, Miller KD. Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer. Npj Breast Cancer. 2022;8:16.","journal-title":"Npj Breast Cancer"},{"key":"2243_CR172","doi-asserted-by":"publisher","first-page":"21113","DOI":"10.1074\/jbc.M211304200","volume":"278","author":"H Peinado","year":"2003","unstructured":"Peinado H, Quintanilla M, Cano A. Transforming growth factor \u03b2-1 induces snail transcription factor in epithelial cell lines -: Mechanisms for epithelial mesenchymal transitions. J Biol Chem. 2003;278:21113\u201323.","journal-title":"J Biol Chem"},{"key":"2243_CR173","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RYJ, Jackson RA, Thiery JP. Emt: 2016. Cell. 2016;166:21\u201345.","journal-title":"Cell"},{"key":"2243_CR174","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1056\/NEJMra0805239","volume":"359","author":"AC Chiang","year":"2008","unstructured":"Chiang AC, Massagu\u00e9 J. Molecular origins of cancer molecular basis of metastasis. New Engl J Med. 2008;359:2814\u201323.","journal-title":"New Engl J Med"},{"key":"2243_CR175","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nrc2622","volume":"9","author":"DX Nguyen","year":"2009","unstructured":"Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009;9:274-U265.","journal-title":"Nat Rev Cancer"},{"key":"2243_CR176","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1172\/JCI30740","volume":"117","author":"S Biswas","year":"2007","unstructured":"Biswas S, Guix M, Rinehart C, Dugger TC, Chytil A, Moses HL, Freeman ML, Arteaga CL. Inhibition of TGF-\u03b2 with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. J Clin Investig. 2007;117:1305\u201313.","journal-title":"J Clin Investig"},{"key":"2243_CR177","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1053\/j.gastro.2016.10.015","volume":"152","author":"B Jung","year":"2017","unstructured":"Jung B, Staudacher JJ, Beauchamp D. Transforming growth factor \u03b2 superfamily signaling in development of colorectal cancer. Gastroenterology. 2017;152:36\u201352.","journal-title":"Gastroenterology"},{"key":"2243_CR178","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.semcancer.2017.02.006","volume":"44","author":"TB Steinbichler","year":"2017","unstructured":"Steinbichler TB, Dud\u00e1s J, Riechelmann H, Skvortsova II. The role of exosomes in cancer metastasis. Semin Cancer Biol. 2017;44:170\u201381.","journal-title":"Semin Cancer Biol"},{"key":"2243_CR179","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.4049\/jimmunol.175.2.1197","volume":"175","author":"T Hagemann","year":"2005","unstructured":"Hagemann T, Wilson J, Kulbe H, Li NFF, Leinster DA, Charles K, Klemm F, Pukrop T, Binder C, Balkwill FR. Macrophages induce invasiveness of epithelial cancer cells via NF-\u03baB and JNK. J Immunol. 2005;175:1197\u2013205.","journal-title":"J Immunol"},{"key":"2243_CR180","doi-asserted-by":"publisher","first-page":"5708","DOI":"10.1158\/0008-5472.CAN-06-4375","volume":"67","author":"TM Robinson-Smith","year":"2007","unstructured":"Robinson-Smith TM, Isaacsohn I, Mercer CA, Zhou MF, Van Rooijen N, Husseinzadeh N, McFarland-Mancini MM, Drew AF. Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice. Can Res. 2007;67:5708\u201316.","journal-title":"Can Res"},{"key":"2243_CR181","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1084\/jem.193.6.727","volume":"193","author":"EY Lin","year":"2001","unstructured":"Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med. 2001;193:727\u201339.","journal-title":"J Exp Med"},{"key":"2243_CR182","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12943-023-01839-2","volume":"22","author":"LB An","year":"2023","unstructured":"An LB, Li MY, Jia QG. Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma. Mol Cancer. 2023;22:140.","journal-title":"Mol Cancer"},{"key":"2243_CR183","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.3390\/ijms20133212","volume":"20","author":"M Jarosz-Biej","year":"2019","unstructured":"Jarosz-Biej M, Smolarczyk R, Cichon T, Kulach N. Tumor microenvironment as a \u201cGame Changer\u201d in cancer radiotherapy. Int J Mol Sci. 2019;20:3212.","journal-title":"Int J Mol Sci"},{"key":"2243_CR184","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nature05630","volume":"446","author":"CF Higgins","year":"2007","unstructured":"Higgins CF. Multiple molecular mechanisms for multidrug resistance transporters. Nature. 2007;446:749\u201357.","journal-title":"Nature"},{"key":"2243_CR185","doi-asserted-by":"publisher","first-page":"5259","DOI":"10.7150\/thno.29098","volume":"8","author":"Y Jo","year":"2018","unstructured":"Jo Y, Choi N, Kim K, Koo HJ, Choi J, Kim HN. Chemoresistance of cancer cells: requirements of tumor microenvironment-mimicking models in anti-cancer drug development. Theranostics. 2018;8:5259\u201375.","journal-title":"Theranostics"},{"key":"2243_CR186","doi-asserted-by":"publisher","first-page":"1480-+","DOI":"10.1016\/j.ccell.2023.06.007","volume":"41","author":"HM Jeon","year":"2023","unstructured":"Jeon HM, Kim JY, Cho HJ, Lee WJ, Nguyen D, Kim SS, Oh YT, Kim HJ, Hubert CG, Jung CW, Pinero G, Joshi T, Sakaguchi T, Hambardzumyan D, Mcintyre TM, Fine HA, Gladson CL, Wang BC, Purow BW, Park JB, Park MJ, Nam D, Lee J. Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling. Cancer Cell. 2023;41:1480-+.","journal-title":"Cancer Cell"},{"key":"2243_CR187","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nrd4003","volume":"12","author":"EJ Moding","year":"2013","unstructured":"Moding EJ, Kastan MB, Kirsch DG. Strategies for optimizing the response of cancer and normal tissues to radiation. Nat Rev Drug Discovery. 2013;12:526\u201342.","journal-title":"Nat Rev Drug Discovery"},{"key":"2243_CR188","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1101\/gad.180331.111","volume":"25","author":"T Shree","year":"2011","unstructured":"Shree T, Olson OC, Elie BT, Kester JC, Garfall AL, Simpson K, Bell-McGuinn KM, Zabor EC, Brogi E, Joyce JA. Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer. Gene Dev. 2011;25:2465\u201379.","journal-title":"Gene Dev"},{"key":"2243_CR189","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21:309\u201322.","journal-title":"Cancer Cell"},{"key":"2243_CR190","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cyto.2008.01.016","volume":"42","author":"WJ Zhang","year":"2008","unstructured":"Zhang WJ, Li BH, Yang XZ, Li PD, Yuan Q, Liu XH, Xu SB, Zhang Y, Yuan J, Gerhard GS, Masker KK, Dong C, Koltun WA, Chorney MJ. IL-4-induced Stat6 activities affect apoptosis and gene expression in breast cancer cells. Cytokine. 2008;42:39\u201347.","journal-title":"Cytokine"},{"key":"2243_CR191","doi-asserted-by":"publisher","first-page":"1359-+","DOI":"10.1038\/nm.2890","volume":"18","author":"Y Sun","year":"2012","unstructured":"Sun Y, Campisi J, Higano C, Beer TM, Porter P, Coleman I, True L, Nelson PS. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat Med. 2012;18:1359-+.","journal-title":"Nat Med"},{"key":"2243_CR192","first-page":"823","volume":"2","author":"YF Xia","year":"2014","unstructured":"Xia YF, Shen S, Verma IM. NF-\u03baB, an active player in human cancers, cancer. Immunol Res. 2014;2:823\u201330.","journal-title":"Immunol Res"},{"key":"2243_CR193","first-page":"988","volume":"62","author":"K Sahin","year":"2010","unstructured":"Sahin K, Sahin N, Kucuk O. Lycopene and chemotherapy toxicity, nutrition and cancer-an. Int J. 2010;62:988\u201395.","journal-title":"Int J"},{"key":"2243_CR194","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.lfs.2010.06.014","volume":"87","author":"K Sahin","year":"2010","unstructured":"Sahin K, Tuzcu M, Gencoglu H, Dogukan A, Timurkan M, Sahin N, Aslan A, Kucuk O. Epigallocatechin-3-gallate activates Nrf2\/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Life Sci. 2010;87:240\u20135.","journal-title":"Life Sci"},{"key":"2243_CR195","doi-asserted-by":"publisher","first-page":"25","DOI":"10.15430\/JCP.2018.23.1.25","volume":"23","author":"K Sahin","year":"2018","unstructured":"Sahin K, Yenice E, Tuzcu M, Orhan C, Mizrak C, Ozercan IH, Sahin N, Yilmaz B, Bilir B, Ozpolat B, Kucuk O. Lycopene protects against spontaneous ovarian cancer formation in laying hens. Journal of cancer prevention. 2018;23:25\u201336.","journal-title":"Journal of cancer prevention"},{"key":"2243_CR196","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1080\/10408398.2021.1976721","volume":"63","author":"TK Sahin","year":"2023","unstructured":"Sahin TK, Bilir B, Kucuk O. Modulation of inflammation by phytochemicals to enhance efficacy and reduce toxicity of cancer chemotherapy. Crit Rev Food Sci. 2023;63:2494\u2013508.","journal-title":"Crit Rev Food Sci"},{"key":"2243_CR197","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/jcb.22601","volume":"110","author":"G Gatouillat","year":"2010","unstructured":"Gatouillat G, Balasse E, Joseph-Pietras D, Morjani H, Madoulet C. Resveratrol induces cell-cycle disruption and apoptosis in chemoresistant B16 melanoma. J Cell Biochem. 2010;110:893\u2013902.","journal-title":"J Cell Biochem"},{"key":"2243_CR198","first-page":"919","volume":"62","author":"A Goel","year":"2010","unstructured":"Goel A, Aggarwal BB. Curcumin, the Golden Spice From Indian Saffron, Is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs, nutrition and cancer-an. Int J. 2010;62:919\u201330.","journal-title":"Int J"},{"key":"2243_CR199","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.3390\/ijms20102454","volume":"20","author":"NI Ismail","year":"2019","unstructured":"Ismail NI, Othman I, Abas F, Lajis NH, Naidu R. Mechanism of apoptosis induced by curcumin in colorectal cancer. Int J Mol Sci. 2019;20:2454.","journal-title":"Int J Mol Sci"},{"key":"2243_CR200","doi-asserted-by":"publisher","first-page":"12173","DOI":"10.1002\/jcp.27955","volume":"234","author":"A Ahmadi","year":"2019","unstructured":"Ahmadi A, Najafi M, Farhood B, Mortezaee K. Transforming growth factor-\u03b2 signaling: tumorigenesis and targeting for cancer therapy. J Cell Physiol. 2019;234:12173\u201387.","journal-title":"J Cell Physiol"},{"key":"2243_CR201","doi-asserted-by":"publisher","first-page":"104745","DOI":"10.1016\/j.phrs.2020.104745","volume":"155","author":"B Farhood","year":"2020","unstructured":"Farhood B, Khodamoradi E, Hoseini-Ghahfarokhi M, Motevaseli E, Mirtavoos-Mahyari H, Musa AE, Najafi M. TGF-\u03b2 in radiotherapy: mechanisms of tumor resistance and normal tissues injury. Pharmacol Res. 2020;155:104745.","journal-title":"Pharmacol Res"},{"key":"2243_CR202","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cytogfr.2023.04.001","volume":"71\u201372","author":"M Turati","year":"2023","unstructured":"Turati M, Mousset A, Issa N, Turtoi A, Ronca R. TGF-\u03b2 mediated drug resistance in solid cancer. Cytokine Growth F R. 2023;71\u201372:54\u201365.","journal-title":"Cytokine Growth F R"},{"key":"2243_CR203","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.biopha.2018.12.055","volume":"111","author":"P Yadav","year":"2019","unstructured":"Yadav P, Shankar BS. Radio resistance in breast cancer cells is mediated through TGF-\u03b2 signalling, hybrid epithelial-mesenchymal phenotype and cancer stem cells. Biomed Pharmacother. 2019;111:119\u201330.","journal-title":"Biomed Pharmacother"},{"key":"2243_CR204","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1158\/1078-0432.CCR-17-3322","volume":"24","author":"SC Formenti","year":"2018","unstructured":"Formenti SC, Lee P, Adams S, Goldberg JD, Li X, Xie MW, Ratikan JA, Felix C, Hwang L, Faull KF, Sayre JW, Hurvitz S, Glaspy JA, Comin-Anduix B, Demaria S, Schaue D, McBride WH. Focal irradiation and systemic TGF\u03b2 blockade in metastatic breast cancer. Clin Cancer Res. 2018;24:2493\u2013504.","journal-title":"Clin Cancer Res"},{"key":"2243_CR205","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.1172\/JCI63428","volume":"123","author":"SC Liu","year":"2013","unstructured":"Liu SC, Tsang NM, Chiang WC, Chang KP, Hsueh C, Liang Y, Juang JL, Chow KPN, Chang YS. Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance. J Clin Investig. 2013;123:5269\u201383.","journal-title":"J Clin Investig"},{"key":"2243_CR206","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1158\/1078-0432.CCR-21-1888","volume":"29","author":"RM Hallett","year":"2023","unstructured":"Hallett RM, Bonfill-Teixidor E, Iurlaro R, Arias A, Raman S, Bayliss P, Egorova O, Neva-Alejo A, McGray AJR, Lau E, Bosch A, Beilschmidt M, Maetzel D, Fransson J, Huber-Ruano I, Anido J, Julien JP, Giblin P, Seoane J. Therapeutic targeting of LIF overcomes macrophage-mediated immunosuppression of the local tumor microenvironment. Clin Cancer Res. 2023;29:791\u2013804.","journal-title":"Clin Cancer Res"},{"key":"2243_CR207","doi-asserted-by":"publisher","first-page":"8334","DOI":"10.3390\/ijms22158334","volume":"22","author":"A Abaurrea","year":"2021","unstructured":"Abaurrea A, Araujo AM, Caffarel MM. The role of the IL-6 cytokine family in epithelial-mesenchymal plasticity in cancer progression. Int J Mol Sci. 2021;22:8334.","journal-title":"Int J Mol Sci"},{"key":"2243_CR208","doi-asserted-by":"publisher","first-page":"e007530","DOI":"10.1136\/jitc-2023-007530","volume":"11","author":"MF Soler","year":"2023","unstructured":"Soler MF, Abaurrea A, Azcoaga P, Araujo AM, Caffarel MM. New perspectives in cancer immunotherapy: targeting IL-6 cytokine family. J Immunother Cancer. 2023;11:e007530.","journal-title":"J Immunother Cancer"},{"key":"2243_CR209","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1158\/2159-8290.CD-17-1033","volume":"8","author":"LM Chen","year":"2018","unstructured":"Chen LM, Diao LX, Yang YB, Yi XH, Rodriguez L, Li YL, Villalobos PA, Cascone T, Liu X, Tan L, Lorenzi PL, Huang AF, Zhao Q, Peng D, Fradette JJ, Peng DH, Ungewiss C, Roybal J, Tong P, Oba J, Skoulidis F, Peng WY, Carter BW, Gay CM, Fan YH, Class CA, Zhu JF, Rodriguez-Canales J, Kawakami M, Byers LA, Woodman SE, Papadimitrakopoulou VA, Dmitrovsky E, Wang J, Ullrich SE, Wistuba II, Heymach JV, Qin FXF, Gibbons DL. CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1\/PD-L1 blockade. Cancer Discov. 2018;8:1156\u201375.","journal-title":"Cancer Discov"},{"key":"2243_CR210","doi-asserted-by":"crossref","unstructured":"XY Li, AK Moesta, C Xiao, K Nakamura, M Casey, HY Zhang, J Madore, A Lepletier, AR Aguilera, A Sundarrajan, C Jacoberger-Foissac, C Wong, T dela Cruz, M Welch, AG Lerner, BN Spatola, VB Soros, J Corbin, AC Anderson, M Effern, M H\u00f6lzel, SC Robson, RL Johnston, N Waddell, C Smith, T Bald, N Geetha, C Beers, MWL Teng, MJ Smyth, Targeting CD39 in cancer reveals an extracellular ATP- and inflammasome-driven tumor immunity. Cancer Discov. 2019;9:1754\u20131773.","DOI":"10.1158\/2159-8290.CD-19-0541"},{"key":"2243_CR211","first-page":"506","volume":"3","author":"PA Beavis","year":"2015","unstructured":"Beavis PA, Milenkovski N, Henderson MA, John LB, Allard B, Loi S, Kershaw MH, Stagg J, Darcy PK. Adenosine receptor 2A blockade increases the efficacy of anti-PD-1 through enhanced antitumor T-cell responses, cancer. Immunol Res. 2015;3:506\u201317.","journal-title":"Immunol Res"},{"key":"2243_CR212","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1093\/ecco-jcc\/jjz058","volume":"13","author":"SY Loo","year":"2019","unstructured":"Loo SY, Vutcovici M, Bitton A, Lakatos PL, Azoulay L, Suissa S, Brassard P. Risk of malignant cancers in inflammatory bowel disease. J Crohns Colitis. 2019;13:1302\u201310.","journal-title":"J Crohns Colitis"},{"key":"2243_CR213","doi-asserted-by":"publisher","first-page":"486","DOI":"10.2174\/156652410791608252","volume":"10","author":"P Brest","year":"2010","unstructured":"Brest P, Corcelle EA, Cesaro A, Chargui A, Bela\u00efd A, Klionsky DJ, Vouret-Craviari V, Hebuterne X, Hofman P, Mograbi B. Autophagy and Crohn\u2019s disease: at the crossroads of infection, inflammation, immunity, and cancer. Curr Mol Med. 2010;10:486\u2013502.","journal-title":"Curr Mol Med"},{"key":"2243_CR214","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/gutjnl-2020-322450","volume":"70","author":"JE Axelrad","year":"2021","unstructured":"Axelrad JE, Ol\u00e9n O, Sachs MC, Erichsen R, Pedersen L, Halfvarson J, Askling J, Ekbom A, Sorensen HT, Ludvigsson JF. Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden. Gut. 2021;70:297\u2013308.","journal-title":"Gut"},{"key":"2243_CR215","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2018.12.002","volume":"45","author":"MF Neurath","year":"2019","unstructured":"Neurath MF. IL-23 in inflammatory bowel diseases and colon cancer. Cytokine Growth F R. 2019;45:1\u20138.","journal-title":"Cytokine Growth F R"},{"key":"2243_CR216","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1586\/17474124.2015.1003208","volume":"9","author":"A Parian","year":"2015","unstructured":"Parian A, Lazarev M. Who and how to screen for cancer in at-risk inflammatory bowel disease patients. Expert Rev Gastroent. 2015;9:731\u201346.","journal-title":"Expert Rev Gastroent"},{"key":"2243_CR217","unstructured":"L Beaugerie, F Carrat, S Nahon, JD Zeitoun, JM Sabat\u00e9, L Peyrin-Biroulet, JF Colombel, M Allez, JF Fl\u00e9jou, J Kirchgesner, M Svrcek, CSA Aux. High risk of anal and rectal cancer in patients with Anal and\/or Perianal Crohn's disease. Clin Gastroenterol H. 2018;16:892-+."},{"key":"2243_CR218","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cell.2004.07.013","volume":"118","author":"FR Greten","year":"2004","unstructured":"Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF, Karin M. IKK\u03b2 links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004;118:285\u201396.","journal-title":"Cell"},{"key":"2243_CR219","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/apt.13970","volume":"45","author":"AJ Yarur","year":"2017","unstructured":"Yarur AJ, Kanagala V, Stein DJ, Czul F, Quintero MA, Agrawal D, Patel A, Best K, Fox C, Idstein K, Abreu MT. Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn\u2019s disease. Aliment Pharm Ther. 2017;45:933\u201340.","journal-title":"Aliment Pharm Ther"},{"key":"2243_CR220","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11894-020-0747-9","volume":"22","author":"J Kimmel","year":"2020","unstructured":"Kimmel J, Axelrad J. The complex interplay between inflammatory bowel disease and malignancy. Curr Gastroenterol Rep. 2020;22:1.","journal-title":"Curr Gastroenterol Rep"},{"key":"2243_CR221","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1007\/s10238-023-01151-9","volume":"23","author":"JY Ou","year":"2023","unstructured":"Ou JY, Zou L, Wu YQ, Zhang QM, Fang YY, Qiu M, Tian XJ, Ma LL, Bi H, Liu C. Causal inference between rheumatoid arthritis and prostate cancer. Clin Exp Med. 2023;23:4681\u201394.","journal-title":"Clin Exp Med"},{"key":"2243_CR222","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jtho.2023.10.006","volume":"19","author":"MH Cho","year":"2024","unstructured":"Cho MH, Cho JH, Eun Y, Han K, Jung J, Cho IY, Yoo JE, Lee HY, Kim H, Park SY, Shin DW. Rheumatoid arthritis and risk of lung cancer: a nationwide cohort study. J Thorac Oncol. 2024;19:216\u201326.","journal-title":"J Thorac Oncol"},{"key":"2243_CR223","first-page":"471","volume":"36","author":"HW Tseng","year":"2018","unstructured":"Tseng HW, Lu LY, Lam HC, Tsai KW, Huang WC, Shiue YL. The influence of disease-modifying anti-rheumatic drugs and corticosteroids on the association between rheumatoid arthritis and skin cancer: a nationwide retrospective case-control study in Taiwan. Clin Exp Rheumatol. 2018;36:471\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"2243_CR224","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/hon.2525","volume":"36","author":"A Klein","year":"2018","unstructured":"Klein A, Polliack A, Gafter-Gvili A. Rheumatoid arthritis and lymphoma: incidence, pathogenesis, biology, and outcome. Hematol Oncol. 2018;36:733\u20139.","journal-title":"Hematol Oncol"},{"key":"2243_CR225","doi-asserted-by":"publisher","first-page":"dyae006","DOI":"10.1093\/ije\/dyae006","volume":"53","author":"TYO Yang","year":"2024","unstructured":"Yang TYO, Floud S, Reeves GK, Study MW. Rheumatoid arthritis and cancer risk in the million women study. Int J Epidemiol. 2024;53:dyae006.","journal-title":"Int J Epidemiol"},{"key":"2243_CR226","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2217\/fon-2019-0722","volume":"16","author":"S Morand","year":"2020","unstructured":"Morand S, Staats H, Creeden JF, Iqbal A, Kahaleh B, Stanbery L, Dworkin L, Nemunaitis J. Molecular mechanisms underlying rheumatoid arthritis and cancer development and treatment. Future Oncol. 2020;16:483\u201395.","journal-title":"Future Oncol"},{"key":"2243_CR227","doi-asserted-by":"publisher","first-page":"681678","DOI":"10.1155\/2014\/681678","volume":"2014","author":"S Bugatti","year":"2014","unstructured":"Bugatti S, Vitolo B, Caporali R, Montecucco C, Manzo A. B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers. BioMed Res Int. 2014;2014:681678.","journal-title":"BioMed Res Int"},{"key":"2243_CR228","first-page":"560","volume":"118","author":"BK Popivanova","year":"2008","unstructured":"Popivanova BK, Kitamura K, Wu Y, Kondo T, Kagaya T, Kaneko S, Oshima M, Fujii C, Mukaida N. Blocking TNF-\u03b1 in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Investig. 2008;118:560\u201370.","journal-title":"J Clin Investig"},{"key":"2243_CR229","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1002\/ijc.21734","volume":"118","author":"MK Choo","year":"2006","unstructured":"Choo MK, Sakurai H, Koizumi K, Saiki I. TAK1-mediated stress signaling pathways are essential for TNF-\u03b1-promoted pulmonary metastasis of murine colon cancer cells. Int J Cancer. 2006;118:2758\u201364.","journal-title":"Int J Cancer"},{"key":"2243_CR230","doi-asserted-by":"crossref","unstructured":"SB Cohen, Y Tanaka, X Mariette, JR Curtis, EB Lee, P Nash, KL Winthrop, C Charles-Schoeman, K Thirunavukkarasu, R DeMasi, J Geier, K Kwok, L Wang, R Riese, J Wollenhaupt. Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials. Ann Rheum Dis. 2017;76:1253\u20131262.","DOI":"10.1136\/annrheumdis-2016-210457"},{"key":"2243_CR231","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/rheumatology\/key287","volume":"58","author":"M Harigai","year":"2019","unstructured":"Harigai M. Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis. Rheumatology. 2019;58:34\u201342.","journal-title":"Rheumatology"},{"key":"2243_CR232","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/S0140-6736(22)00794-2","volume":"399","author":"C Catassi","year":"2022","unstructured":"Catassi C, Verdu EF, Bai JC, Lionetti E. Coeliac disease. Lancet. 2022;399:2413\u201326.","journal-title":"Lancet"},{"key":"2243_CR233","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1053\/j.gastro.2005.02.027","volume":"128","author":"C Catassi","year":"2005","unstructured":"Catassi C, Bearzi I, Holmes GKT. Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology. 2005;128:S79\u201386.","journal-title":"Gastroenterology"},{"key":"2243_CR234","doi-asserted-by":"publisher","first-page":"1686-+","DOI":"10.1053\/j.gastro.2020.07.007","volume":"159","author":"L Emilsson","year":"2020","unstructured":"Emilsson L, Semrad C, Lebwohl B, Green PHR, Ludvigsson JF. Risk of small bowel adenocarcinoma, adenomas, and carcinoids in a nationwide cohort of individuals with celiac disease. Gastroenterology. 2020;159:1686-+.","journal-title":"Gastroenterology"},{"key":"2243_CR235","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1001\/jama.2020.1943","volume":"323","author":"B Lebwohl","year":"2020","unstructured":"Lebwohl B, Green PHR, S\u00f6derling J, Roelstraete B, Ludvigsson JF. Association between celiac disease and mortality risk in a Swedish population. Jama-J Am Med Assoc. 2020;323:1277\u201385.","journal-title":"Jama-J Am Med Assoc"},{"key":"2243_CR236","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/2050640617707868","volume":"6","author":"L Emilsson","year":"2018","unstructured":"Emilsson L, Lebwohl B, Green PHR, Murray JA, M\u00e5rild K, Ludvigsson JF. Mucosal healing and the risk of serious infections in patients with celiac disease. United Eur Gastroent. 2018;6:55\u201362.","journal-title":"United Eur Gastroent"},{"key":"2243_CR237","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1177\/2050640619844125","volume":"7","author":"A Al-Toma","year":"2019","unstructured":"Al-Toma A, Volta U, Auricchio R, Castillejo G, Sanders DS, Cellier C, Mulder CJ, Lundin KEA. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United Eur Gastroent. 2019;7:583\u2013613.","journal-title":"United Eur Gastroent"},{"key":"2243_CR238","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.3390\/foods10102351","volume":"10","author":"AK Verma","year":"2021","unstructured":"Verma AK, Mandal S, Tiwari A, Monachesi C, Catassi GN, Srivastava A, Gatti S, Lionetti E, Catassi C. Current status and perspectives on the application of CRISPR\/Cas9 gene-editing system to develop a low-gluten, non-transgenic wheat variety. Foods. 2021;10:2351.","journal-title":"Foods"},{"key":"2243_CR239","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.3390\/nu13124548","volume":"13","author":"MH Guzm\u00e1n-L\u00f3pez","year":"2021","unstructured":"Guzm\u00e1n-L\u00f3pez MH, S\u00e1nchez-Le\u00f3n S, Mar\u00edn-Sanz M, Comino I, Segura V, Vaquero L, Rivero-Lezcano OM, Pastor J, Sousa C, Vivas S, Barro F. Oral consumption of bread from an RNAi wheat line with strongly silenced gliadins elicits no immunogenic response in a pilot study with celiac disease patients. Nutrients. 2021;13:4548.","journal-title":"Nutrients"},{"key":"2243_CR240","doi-asserted-by":"publisher","first-page":"155095","DOI":"10.1016\/j.phymed.2023.155095","volume":"122","author":"X Liu","year":"2024","unstructured":"Liu X, Yan CL, Chang CX, Meng FS, Shen WJ, Wang S, Zhang Y. Ochratoxin A promotes chronic enteritis and early colorectal cancer progression by targeting signaling. Phytomedicine. 2024;122:155095.","journal-title":"Phytomedicine"},{"key":"2243_CR241","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/ijc.32688","volume":"146","author":"JS Nahand","year":"2020","unstructured":"Nahand JS, Moghoofei M, Salmaninejad A, Bahmanpour Z, Karimzadeh M, Nasiri M, Mirzaei HR, Pourhanifeh MH, Bokharaei-Salim F, Mirzaei H, Hamblin MR. Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: a review. Int J Cancer. 2020;146:305\u201320.","journal-title":"Int J Cancer"},{"key":"2243_CR242","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1158\/1055-9965.EPI-10-0184","volume":"19","author":"TJ Kemp","year":"2010","unstructured":"Kemp TJ, Hildesheim A, Garc\u00eda-Pi\u00f1eres A, Williams MC, Shearer GM, Rodriguez AC, Schiffman M, Burk R, Freer E, Bonilla J, Herrero R, Pinto LA. Elevated systemic levels of inflammatory cytokines in older women with persistent cervical human papillomavirus infection. Cancer Epidem Biomar. 2010;19:1954\u20139.","journal-title":"Cancer Epidem Biomar"},{"key":"2243_CR243","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.canlet.2013.08.016","volume":"345","author":"F Wang","year":"2014","unstructured":"Wang F, Meng WB, Wang BY, Qiao L. induced gastric inflammation and gastric cancer. Cancer Lett. 2014;345:196\u2013202.","journal-title":"Cancer Lett"},{"key":"2243_CR244","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","volume":"386","author":"A Schweitzer","year":"2015","unstructured":"Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546\u201355.","journal-title":"Lancet"},{"key":"2243_CR245","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000173419","volume":"75","author":"SR Kim","year":"2008","unstructured":"Kim SR, Kudo M, Hino O, Han KH, Chung YH, Lee HS. Epidemiology of hepatocellular carcinoma in Japan and Korea. Oncology. 2008;75:13\u20136.","journal-title":"Oncology"},{"key":"2243_CR246","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s11684-013-0256-4","volume":"7","author":"BC Sun","year":"2013","unstructured":"Sun BC, Karin M. Inflammation and liver tumorigenesis. Front Med-Prc. 2013;7:242\u201354.","journal-title":"Front Med-Prc"},{"key":"2243_CR247","doi-asserted-by":"crossref","unstructured":"LH Liu, B Wang, YB Ma, KH Sun, P Wang, MF Li, JL Dong, MR Qin, MS Li, CS Wei, Y Tan, JS He, KY Guo, XA Yu. A review of L. in the treatment of liver disease: viral hepatitis, liver fibrosis\/cirrhosis and hepatocellular carcinoma. Front Pharmacol. 2024;15:1443667.","DOI":"10.3389\/fphar.2024.1443667"},{"key":"2243_CR248","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.3748\/wjg.v25.i27.3527","volume":"25","author":"TY Li","year":"2019","unstructured":"Li TY, Yang Y, Zhou G, Tu ZK. Immune suppression in chronic hepatitis B infection associated liver disease: A review. World J Gastroenterol. 2019;25:3527\u201337.","journal-title":"World J Gastroenterol"},{"key":"2243_CR249","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.aaa4972","volume":"348","author":"WS Garrett","year":"2015","unstructured":"Garrett WS. Cancer and the microbiota. Science. 2015;348:80\u20136.","journal-title":"Science"},{"key":"2243_CR250","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.chom.2016.03.007","volume":"19","author":"AR Moschen","year":"2016","unstructured":"Moschen AR, Gerner RR, Wang J, Klepsch V, Adolph TE, Reider SJ, Hackl H, Pfister A, Schilling J, Moser PL, Kempster SL, Swidsinski A, Orth-H\u00f6ller D, Weiss G, Baines JF, Kaser A, Tilg H. Lipocalin 2 Protects from Inflammation and Tumorigenesis Associated with Gut Microbiota Alterations. Cell Host Microbe. 2016;19:455\u201369.","journal-title":"Cell Host Microbe"},{"key":"2243_CR251","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41585-020-0286-z","volume":"17","author":"P Laniewski","year":"2020","unstructured":"Laniewski P, Ilhan ZE, Herbst-Kralovetz MM. The microbiome and gynaecological cancer development, prevention and therapy. Nat Rev Urol. 2020;17:232\u201350.","journal-title":"Nat Rev Urol"},{"key":"2243_CR252","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, Cogdill AP, Zhao L, Hudgens CW, Hutchinson DS, Manzo T, de Macedo MP, Cotechini T, Kumar T, Chen WS, Reddy SM, Sloane RS, Galloway-Pena J, Jiang H, Chen PL, Shpall EJ, Rezvani K, Alousi AM, Chemaly RF, Shelburne S, Vence LM, Okhuysen PC, Jensen VB, Swennes AG, McAllister F, Sanchez EMR, Zhang Y, Le Chatelier E, Zitvogel L, Pons N, Austin-Breneman JL, Haydu LE, Burton EM, Gardner JM, Sirmans E, Hu J, Lazar AJ, Tsujikawa T, Diab A, Tawbi H, Glitza IC, Hwu WJ, Patel SP, Woodman SE, Amaria RN, Davies MA, Gershenwald JE, Hwu P, Lee JE, Zhang J, Coussens LM, Cooper ZA, Futreal PA, Daniel CR, Ajami NJ, Petrosino JF, Tetzlaff MT, Sharma P, Allison JP, Jenq RR, Wargo JA. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2018;359:97\u2013103.","journal-title":"Science"},{"key":"2243_CR253","doi-asserted-by":"publisher","first-page":"104-+","DOI":"10.1126\/science.aao3290","volume":"359","author":"V Matson","year":"2018","unstructured":"Matson V, Fessler J, Bao R, Chongsuwat T, Zha YY, Alegre ML, Luke JJ, Gajewski TF. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science. 2018;359:104-+.","journal-title":"Science."},{"key":"2243_CR254","doi-asserted-by":"publisher","first-page":"91-+","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daill\u00e8re R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, Fidelle M, Flament C, Poirier-Colame V, Opolon P, Klein C, Iribarren K, Mondrag\u00f3n L, Jacquelot N, Qu B, Ferrere G, Cl\u00e9menson C, Mezquita L, Masip JR, Naltet C, Brosseau S, Kaderbhai C, Richard C, Rizvi H, Levenez F, Galleron N, Quinquis B, Pons N, Ryffel B, Minard-Colin V, Gonin P, Soria JC, Deutsch E, Loriot Y, Ghiringhelli F, Zalcman G, Goldwasser F, Escudier B, Hellmann MD, Eggermont A, Raoult D, Albiges L, Kroemer G, Zitvogel L. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359:91-+.","journal-title":"Science"},{"key":"2243_CR255","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3389\/fimmu.2017.01353","volume":"8","author":"M Spiljar","year":"2017","unstructured":"Spiljar M, Merkler D, Trajkovski M. The immune system bridges the gut microbiota with systemic energy homeostasis: focus on TLRs, mucosal barrier, and SCFAs. Front Immunol. 2017;8:1353.","journal-title":"Front Immunol"},{"key":"2243_CR256","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Lei YM, Jabri B, Alegre ML, Chang EB, Gajewski TF. Commensal promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 2015;350:1084\u20139.","journal-title":"Science"},{"key":"2243_CR257","doi-asserted-by":"publisher","first-page":"1383258","DOI":"10.3389\/fonc.2024.1383258","volume":"14","author":"GG Salme\u00e1n","year":"2024","unstructured":"Salme\u00e1n GG, Gonz\u00e1lez MD, Escalona AAR, Islas JAL, Castro-Eguiluz D. Effects of prebiotics, probiotics, and synbiotics on the prevention and treatment of cervical cancer: Mexican consensus and recommendations. Front Oncol. 2024;14:1383258.","journal-title":"Front Oncol"},{"key":"2243_CR258","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.tig.2022.10.004","volume":"39","author":"I Orsolic","year":"2023","unstructured":"Orsolic I, Carrier A, Esteller M. Genetic and epigenetic defects of the RNA modification machinery in cancer. Trends Genet. 2023;39:74\u201388.","journal-title":"Trends Genet"},{"key":"2243_CR259","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436\u201344.","journal-title":"Nature"},{"key":"2243_CR260","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ccr.2004.09.028","volume":"6","author":"A Sparmann","year":"2004","unstructured":"Sparmann A, Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell. 2004;6:447\u201358.","journal-title":"Cancer Cell"},{"key":"2243_CR261","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1101\/gad.1455706","volume":"20","author":"K Shchors","year":"2006","unstructured":"Shchors K, Shchors E, Rostker F, Lawlor ER, Brown-Swigart L, Evan GI. The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1\u03b2. Gene Dev. 2006;20:2527\u201338.","journal-title":"Gene Dev"},{"key":"2243_CR262","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/cac2.12327","volume":"42","author":"CM Liu","year":"2022","unstructured":"Liu CM, Zheng SF, Wang ZY, Wang SH, Wang XF, Yang L, Xu HY, Cao Z, Feng XL, Xue Q, Wang Y, Sun N, He J. G12D mutation drives immune suppression and the primary resistance of anti-PD-1\/PD-L1 immunotherapy in non-small cell lung cancer. Cancer Commun. 2022;42:828\u201347.","journal-title":"Cancer Commun"},{"key":"2243_CR263","first-page":"909","volume":"11","author":"E Markovits","year":"2023","unstructured":"Markovits E, Harush O, Baruch EN, Shulman ED, Debby A, Itzhaki O, Anafi L, Danilevsky A, Shomron N, Ben-Betzalel G, Asher N, Shapira-Frommer R, Schachter J, Barshack I, Geiger T, Elkon R, Besser MJ, Markel G. MYC induces immunotherapy and IFN\u03b3 resistance through downregulation of JAK2, cancer. Immunol Res. 2023;11:909\u201324.","journal-title":"Immunol Res"},{"key":"2243_CR264","doi-asserted-by":"publisher","first-page":"483-+","DOI":"10.1016\/j.ccell.2019.10.001","volume":"36","author":"HY Han","year":"2019","unstructured":"Han HY, Jain AD, Truica MI, Izquierdo-Ferrer J, Anker JF, Lysy B, Sagar V, Luan Y, Chalmers ZR, Unno K, Mok H, Vatapalli R, Yoo YA, Rodriguez Y, Kandela I, Parker JB, Chakravarti D, Mishra RK, Schiltz GE, Abdulkadir SA. Small-molecule MYC inhibitors suppress tumor growth and enhance immunotherapy. Cancer Cell. 2019;36:483-+.","journal-title":"Cancer Cell"},{"key":"2243_CR265","doi-asserted-by":"publisher","first-page":"102154","DOI":"10.1016\/j.ctrv.2021.102154","volume":"94","author":"MJ Duffy","year":"2021","unstructured":"Duffy MJ, O\u2019Grady S, Tang MH, Crown J. MYC as a target for cancer treatment. Cancer Treatment Rev. 2021;94:102154.","journal-title":"Cancer Treatment Rev"},{"key":"2243_CR266","doi-asserted-by":"publisher","first-page":"22473","DOI":"10.1074\/jbc.M500963200","volume":"280","author":"RJ Phillips","year":"2005","unstructured":"Phillips RJ, Mestas J, Gharee-Kermani M, Burdick MD, Sica A, Belperio JA, Keane MP, Strieter RM. Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase\/PTEN\/AKT\/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1\u03b1. J Biol Chem. 2005;280:22473\u201381.","journal-title":"J Biol Chem"},{"key":"2243_CR267","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature01874","volume":"425","author":"P Staller","year":"2003","unstructured":"Staller P, Sulitkova J, Liszlwan J, Moch H, Oakeley EJ, Krek W. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature. 2003;425:307\u201311.","journal-title":"Nature"},{"key":"2243_CR268","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1016\/j.devcel.2024.08.003","volume":"59","author":"C Zhang","year":"2024","unstructured":"Zhang C, Ma HM, Wu S, Shen JM, Zhang N, Xu YL, Li CX, He P, Ge MK, Chu XL, Zhang YX, Zheng JK, Chen GQ, Shen SM. Secreted PTEN binds PLXDC2 on macrophages to drive antitumor immunity and tumor suppression. Dev Cell. 2024;59:3072.","journal-title":"Dev Cell"},{"key":"2243_CR269","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1093\/jnci\/90.21.1583","volume":"90","author":"LM Wahl","year":"1998","unstructured":"Wahl LM, Kleinman HK. Tumor-associated macrophages as targets for cancer therapy. J Natl Cancer Inst. 1998;90:1583\u20134.","journal-title":"J Natl Cancer Inst"},{"key":"2243_CR270","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3109\/07853890.2011.595732","volume":"43","author":"G Germano","year":"2011","unstructured":"Germano G, Mantovani A, Allavena P. Targeting of the innate immunity\/inflammation as complementary anti-tumor therapies. Ann Med. 2011;43:581\u201393.","journal-title":"Ann Med"},{"key":"2243_CR271","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0165-6147(02)02064-3","volume":"23","author":"JJ Onuffer","year":"2002","unstructured":"Onuffer JJ, Horuk R. Chemokines, chemokine receptors and small-molecule antagonists: recent developments. Trends Pharmacol Sci. 2002;23:459\u201367.","journal-title":"Trends Pharmacol Sci"},{"key":"2243_CR272","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ccr.2013.01.008","volume":"23","author":"G Germano","year":"2013","unstructured":"Germano G, Frapolli R, Belgiovine C, Anselmo A, Pesce S, Liguori M, Erba E, Uboldi S, Zucchetti M, Pasqualini F, Nebuloni M, van Rooijen N, Mortarini R, Beltrame L, Marchini S, Nerini IF, Sanfilippo R, Casali PG, Pilotti S, Galmarini CM, Anichini A, Mantovani A, D\u2019Incalci M, Allavena P. Role of macrophage targeting in the antitumor activity of trabectedin. Cancer Cell. 2013;23:249\u201362.","journal-title":"Cancer Cell"},{"key":"2243_CR273","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1158\/2159-8290.CD-12-0362","volume":"3","author":"MV Dieci","year":"2013","unstructured":"Dieci MV, Arnedos M, Andre F, Soria JC. Fibroblast growth factor receptor inhibitors as a cancer treatment: from a biologic rationale to medical perspectives. Cancer Discov. 2013;3:264\u201379.","journal-title":"Cancer Discov"},{"key":"2243_CR274","doi-asserted-by":"publisher","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-11-0945","volume":"17","author":"J Coward","year":"2011","unstructured":"Coward J, Kulbe H, Chakravarty P, Leader D, Vassileva V, Leinster DA, Thompson R, Schioppa T, Nemeth J, Vermeulen J, Singh N, Avril N, Cummings J, Rexhepaj E, Jirstr\u00f6m K, Gallagher WM, Brennan DJ, McNeish IA, Balkwill FR. Interleukin-6 as a therapeutic target in human ovarian cancer. Clin Cancer Res. 2011;17:6083\u201396.","journal-title":"Clin Cancer Res"},{"key":"2243_CR275","doi-asserted-by":"publisher","first-page":"E69","DOI":"10.1200\/JCO.2012.44.2020","volume":"31","author":"K Ando","year":"2013","unstructured":"Ando K, Takahashi F, Motojima S, Nakashima K, Kaneko N, Hoshi K, Takahashi K. Possible role for tocilizumab, an anti-interleukin-6 receptor antibody, treating cancer cachexia. J Clin Oncol. 2013;31:E69\u201372.","journal-title":"J Clin Oncol"},{"key":"2243_CR276","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nm.2999","volume":"19","author":"M Bruchard","year":"2013","unstructured":"Bruchard M, Mignot G, Derang\u00e8re V, Chalmin F, Chevriaux A, V\u00e9gran F, Boireau W, Simon B, Ryffel B, Connat JL, Kanellopoulos J, Martin F, R\u00e9b\u00e9 C, Apetoh L, Ghiringhelli F. Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth. Nat Med. 2013;19:57\u201364.","journal-title":"Nat Med"},{"key":"2243_CR277","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1016\/j.cell.2015.12.008","volume":"163","author":"KT Chow","year":"2015","unstructured":"Chow KT, Gale M. SnapShot: interferon signaling. Cell. 2015;163:1808.","journal-title":"Cell"},{"key":"2243_CR278","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.0105-2896.2004.00204.x","volume":"202","author":"S Pestka","year":"2004","unstructured":"Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev. 2004;202:8\u201332.","journal-title":"Immunol Rev"},{"key":"2243_CR279","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41573-018-0011-2","volume":"18","author":"EC Borden","year":"2019","unstructured":"Borden EC. Interferons \u03b1 and \u03b2 in cancer: therapeutic opportunities from new insights. Nat Rev Drug Discovery. 2019;18:219\u201334.","journal-title":"Nat Rev Drug Discovery"},{"key":"2243_CR280","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nrd2422","volume":"6","author":"EC Borden","year":"2007","unstructured":"Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, Stark GR. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discovery. 2007;6:975\u201390.","journal-title":"Nat Rev Drug Discovery"},{"key":"2243_CR281","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3109\/07357909609012154","volume":"14","author":"PL Triozzi","year":"2009","unstructured":"Triozzi PL, Walker MJ, Pellegrini AE, Dayton MA. Isotretinoin and recombinant interf eron Alfa-2a therapy of metastatic malignant melanoma. Cancer Invest. 2009;14:293\u20138.","journal-title":"Cancer Invest"},{"key":"2243_CR282","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.addr.2019.07.008","volume":"147","author":"T Seya","year":"2019","unstructured":"Seya T, Takeda Y, Matsumoto M. A Toll-like receptor 3 (TLR3) agonist ARNAX for therapeutic immunotherapy. Adv Drug Deliver Rev. 2019;147:37\u201343.","journal-title":"Adv Drug Deliver Rev"},{"key":"2243_CR283","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jconrel.2023.08.006","volume":"361","author":"BL Nguyen","year":"2023","unstructured":"Nguyen BL, Phung CD, Pham DV, Le ND, Jeong JH, Kim J, Kim JH, Chang JH, Jin SG, Choi HG, Ku SK, Kim JO. Liposomal co-delivery of toll-like receptors 3 and 7 agonists induce a hot triple-negative breast cancer immune environment. J Control Release. 2023;361:443\u201354.","journal-title":"J Control Release"},{"key":"2243_CR284","doi-asserted-by":"publisher","first-page":"578-+","DOI":"10.1038\/s41551-018-0236-8","volume":"2","author":"CB Rodell","year":"2018","unstructured":"Rodell CB, Arlauckas SP, Cuccarese MF, Garris CS, Ahmed RLMS, Kohler RH, Pittet MJ, Weissleder R. TLR7\/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy. Nat Biomed Eng. 2018;2:578-+.","journal-title":"Nat Biomed Eng"},{"key":"2243_CR285","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1021\/acs.chemrev.1c00750","volume":"122","author":"KM Garland","year":"2022","unstructured":"Garland KM, Sheehy TL, Wilson JT. Chemical and biomolecular strategies for STING pathway activation in cancer immunotherapy. Chem Rev. 2022;122:5977\u20136039.","journal-title":"Chem Rev"},{"key":"2243_CR286","doi-asserted-by":"publisher","first-page":"806-+","DOI":"10.1038\/s41586-023-05880-5","volume":"616","author":"J Hu","year":"2023","unstructured":"Hu J, S\u00e1nchez-Rivera FJ, Wang ZH, Johnson GN, Ho YJ, Ganesh K, Umeda S, Gan ST, Mujal AM, Delconte RB, Hampton JP, Zhao HY, Kottapalli S, de Stanchina E, Iacobuzio-Donahue CA, Pe\u2019er D, Lowe SW, Sun JC, Massagu\u00e9 J. STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma. Nature. 2023;616:806-+.","journal-title":"Nature"},{"key":"2243_CR287","doi-asserted-by":"publisher","first-page":"e20200844","DOI":"10.1084\/jem.20200844","volume":"218","author":"N Xu","year":"2021","unstructured":"Xu N, Palmer DC, Robeson AC, Shou PS, Bommiasamy H, Laurie SJ, Willis C, Dotti G, Vincent BG, Restifo NP, Serody JS. STING agonist promotes CAR T cell trafficking and in breast cancer. J Exp Med. 2021;218:e20200844.","journal-title":"J Exp Med"},{"key":"2243_CR288","doi-asserted-by":"publisher","first-page":"eaay9013","DOI":"10.1126\/scitranslmed.aay9013","volume":"12","author":"WW Li","year":"2020","unstructured":"Li WW, Lu L, Lu JJ, Wang XR, Yang C, Jin JS, Wu LL, Hong XC, Li FL, Cao DQ, Yang YQ, Wu M, Su B, Cheng JK, Yang XM, Di W, Deng LF. cGAS-STING-mediated DNA sensing maintains CD8 T cell stemness and promotes antitumor T cell therapy. Sci Transl Med. 2020;12:eaay9013.","journal-title":"Sci Transl Med"},{"key":"2243_CR289","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1038\/s41467-019-13094-5","volume":"10","author":"Y Liu","year":"2019","unstructured":"Liu Y, Crowe WN, Wang LL, Lu Y, Petty WJ, Habib AA, Zhao DW. An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases. Nat Commun. 2019;10:5108.","journal-title":"Nat Commun"},{"key":"2243_CR290","doi-asserted-by":"publisher","first-page":"19049","DOI":"10.1038\/srep19049","volume":"6","author":"T Li","year":"2016","unstructured":"Li T, Cheng H, Yuan H, Xu Q, Shu C, Zhang Y, Xu P, Tan J, Rui Y, Li P, Tan X. Antitumor activity of cGAMP via stimulation of cGAS-cGAMP-STING-IRF3 mediated innate immune response. Sci Rep. 2016;6:19049.","journal-title":"Sci Rep"},{"key":"2243_CR291","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-019-0728-4","volume":"7","author":"S Dorta-Estremera","year":"2019","unstructured":"Dorta-Estremera S, Hegde VL, Slay RB, Sun R, Yanamandra AV, Nicholas C, Nookala S, Sierra G, Curran MA, Sastry KJ. Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV oral cancer. J Immunother Cancer. 2019;7:1.","journal-title":"J Immunother Cancer"},{"key":"2243_CR292","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.omtn.2018.11.003","volume":"14","author":"X An","year":"2019","unstructured":"An X, Zhu YY, Zheng TS, Wang GY, Zhang MH, Li JD, Ji HB, Li SJ, Yang SC, Xu DD, Li ZW, Wang TZ, He Y, Zhang L, Yang WW, Zhao R, Hao DP, Li XB. An analysis of the expression and association with immune cell infiltration of the cGAS\/STING pathway in pan-Cancer. Mol Ther-Nucl Acids. 2019;14:80\u20139.","journal-title":"Mol Ther-Nucl Acids"},{"key":"2243_CR293","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1158\/0008-5472.CAN-15-1456","volume":"76","author":"H Lemos","year":"2016","unstructured":"Lemos H, Mohamed E, Huang L, Ou R, Pacholczyk G, Arbab AS, Munn D, Mellor AL. STING promotes the growth of tumors characterized by low antigenicity via IDO activation. Can Res. 2016;76:2076\u201381.","journal-title":"Can Res"},{"key":"2243_CR294","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41422-023-00788-1","volume":"33","author":"SQ Qiu","year":"2023","unstructured":"Qiu SQ, Zhong XY, Meng X, Li ST, Qian XY, Lu H, Cai J, Zhang Y, Wang MJ, Ye ZJ, Zhang HF, Gao P. Mitochondria-localized cGAS suppresses ferroptosis to promote cancer progression. Cell Res. 2023;33:299\u2013311.","journal-title":"Cell Res"},{"key":"2243_CR295","doi-asserted-by":"publisher","first-page":"3405-+","DOI":"10.1016\/j.celrep.2018.11.097","volume":"25","author":"SL Li","year":"2018","unstructured":"Li SL, Hong Z, Wang Z, Li F, Mei JH, Huang LL, Lou XW, Zhao SM, Song LH, Chen W, Wang Q, Liu H, Cai YN, Yu HS, Xu HM, Zeng GZ, Wang QY, Zhu JJ, Liu X, Tan NH, Wang C. The cyclopeptide astin C specifically inhibits the innate immune CDN sensor STING. Cell Rep. 2018;25:3405-+.","journal-title":"Cell Rep"},{"key":"2243_CR296","doi-asserted-by":"crossref","unstructured":"Matthews, N, JF Watkins. Tumour-necrosis factor from the rabbit. I. Mode of action, specificity and physicochemical properties. Brit J Cancer. 1978;38:302\u20139.","DOI":"10.1038\/bjc.1978.202"},{"key":"2243_CR297","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1182\/blood-2011-04-325225","volume":"119","author":"BB Aggarwal","year":"2012","unstructured":"Aggarwal BB, Gupta SC, Kim JH. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood. 2012;119:651\u201365.","journal-title":"Blood"},{"key":"2243_CR298","doi-asserted-by":"publisher","first-page":"780","DOI":"10.12659\/MSM.901880","volume":"23","author":"WY Li","year":"2017","unstructured":"Li WY, Xu J, Zhao J, Zhang R. Oxaliplatin and infliximab combination synergizes in inducing colon cancer regression. Med Sci Monitor. 2017;23:780\u20139.","journal-title":"Med Sci Monitor"},{"key":"2243_CR299","first-page":"351","volume":"1","author":"D Metcalf","year":"2013","unstructured":"Metcalf D. The colony-stimulating factors and cancer, cancer. Immunol Res. 2013;1:351\u20136.","journal-title":"Immunol Res"},{"key":"2243_CR300","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","volume":"54","author":"AJ Ozga","year":"2021","unstructured":"Ozga AJ, Chow MT, Luster AD. Chemokines and the immune response to cancer. Immunity. 2021;54:859\u201374.","journal-title":"Immunity"},{"key":"2243_CR301","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/170381","volume":"2014","author":"N Mukaida","year":"2014","unstructured":"Mukaida N, Sasaki S-I, Baba T. Chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment. Mediators Inflamm. 2014;2014:1\u201315.","journal-title":"Mediators Inflamm"},{"key":"2243_CR302","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.semcancer.2020.09.013","volume":"83","author":"SR Mishra","year":"2022","unstructured":"Mishra SR, Mahapatra KK, Behera BP, Bhol CS, Praharaj PP, Panigrahi DP, Patra S, Singh A, Patil S, Dhiman R, Patra SK, Bhutia SK. Inflammasomes in cancer: effect of epigenetic and autophagic modulations. Semin Cancer Biol. 2022;83:399\u2013412.","journal-title":"Semin Cancer Biol"},{"key":"2243_CR303","first-page":"94","volume":"5","author":"R Karki","year":"2017","unstructured":"Karki R, Man SM, Kanneganti TD. Inflammasomes and cancer, cancer. Immunol Res. 2017;5:94\u20139.","journal-title":"Immunol Res"},{"key":"2243_CR304","doi-asserted-by":"publisher","first-page":"108545","DOI":"10.1016\/j.pharmthera.2023.108545","volume":"251","author":"IW Tengesdal","year":"2023","unstructured":"Tengesdal IW, Dinarello CA, Marchetti C. NLRP3 and cancer: pathogenesis and therapeutic opportunities. Pharmacol Ther. 2023;251:108545.","journal-title":"Pharmacol Ther"},{"key":"2243_CR305","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/imr.12296","volume":"265","author":"SM Man","year":"2015","unstructured":"Man SM, Kanneganti TD. Regulation of inflammasome activation. Immunol Rev. 2015;265:6\u201321.","journal-title":"Immunol Rev"},{"key":"2243_CR306","doi-asserted-by":"crossref","unstructured":"Calabrese L, Fiocco Z, Mellett M, Aoki R, Rubegni P, French LE, Satoh TK. Role of the NLRP1 inflammasome in skin cancer and inflammatory skin diseases. Br J Dermatol. 2024;190(3):305\u201315.","DOI":"10.1093\/bjd\/ljad421"},{"key":"2243_CR307","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s41419-022-05336-0","volume":"13","author":"XR Rao","year":"2022","unstructured":"Rao XR, Zhou XS, Wang G, Jie XH, Xing BY, Xu YZ, Chen YS, Li J, Zhu KK, Wu ZL, Wu G, Wu CY, Zhou R. NLRP6 is required for cancer-derived exosome-modified macrophage M2 polarization and promotes metastasis in small cell lung cancer. Cell Death Dis. 2022;13:891.","journal-title":"Cell Death Dis"},{"key":"2243_CR308","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.4049\/jimmunol.1002046","volume":"185","author":"MH Zaki","year":"2010","unstructured":"Zaki MH, Vogel P, Body-Malapel M, Lamkanfi M, Kanneganti TD. IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation. J Immunol. 2010;185:4912\u201320.","journal-title":"J Immunol"},{"key":"2243_CR309","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.immuni.2010.02.012","volume":"32","author":"J Dupaul-Chicoine","year":"2010","unstructured":"Dupaul-Chicoine J, Yeretssian G, Doiron K, Bergstrom KSB, McIntire CR, LeBlanc PM, Meunier C, Turbide C, Gros P, Beauchemin N, Vallance BA, Saleh M. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity. 2010;32:367\u201378.","journal-title":"Immunity"},{"key":"2243_CR310","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1158\/0008-5472.CAN-12-0509","volume":"72","author":"MT Chow","year":"2012","unstructured":"Chow MT, Sceneay J, Paget C, Wong CSF, Duret H, Tschopp J, M\u00f6ller A, Smyth MJ. NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases. Can Res. 2012;72:5721\u201332.","journal-title":"Can Res"},{"key":"2243_CR311","doi-asserted-by":"publisher","first-page":"5393","DOI":"10.1158\/0008-5472.CAN-11-0993","volume":"71","author":"M Terme","year":"2011","unstructured":"Terme M, Ullrich E, Aymeric L, Meinhardt K, Desbois M, Delahaye N, Viaud S, Ryffel B, Yagita H, Kaplanski G, Pr\u00e9vost-Blondel A, Kato M, Schultze JL, Tartour E, Kroemer G, Chaput N, Zitvogel L. IL-18 induces PD-1-dependent immunosuppression in cancer. Can Res. 2011;71:5393\u20139.","journal-title":"Can Res"},{"key":"2243_CR312","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.4049\/jimmunol.1402098","volume":"194","author":"TM Williams","year":"2015","unstructured":"Williams TM, Leeth RA, Rothschild DE, Coutermarsh-Ott SL, McDaniel DK, Simmons AE, Heid B, Cecere TE, Allen IC. The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis. J Immunol. 2015;194:3369\u201380.","journal-title":"J Immunol"},{"key":"2243_CR313","doi-asserted-by":"publisher","first-page":"7187","DOI":"10.4049\/jimmunol.1100412","volume":"186","author":"GY Chen","year":"2011","unstructured":"Chen GY, Liu MC, Wang FY, Bertin J, N\u00fa\u00f1ez G. A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J Immunol. 2011;186:7187\u201394.","journal-title":"J Immunol"},{"key":"2243_CR314","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/jid.2012.317","volume":"133","author":"WM Liu","year":"2013","unstructured":"Liu WM, Luo YC, Dunn JH, Norris DA, Dinarello CA, Fujita M. Dual role of apoptosis-associated speck-like protein containing a CARD (ASC) in tumorigenesis of human melanoma. J Investig Dermatol. 2013;133:518\u201327.","journal-title":"J Investig Dermatol"},{"key":"2243_CR315","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.trsl.2022.09.002","volume":"252","author":"BR Sharma","year":"2023","unstructured":"Sharma BR, Kanneganti TD. Inflammasome signaling in colorectal cancer. Transl Res. 2023;252:45\u201352.","journal-title":"Transl Res"},{"key":"2243_CR316","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1158\/2767-9764.CRC-23-0065","volume":"3","author":"J Amo-Aparicio","year":"2023","unstructured":"Amo-Aparicio J, Dominguez A, Atif SM, Dinarello A, Azam T, Alula KM, Piper M, Lieu CH, Lentz RW, Leal AD, Bagby SM, Messersmith WA, Karam SD, Dinarello CA, Pitts TM, Marchetti C. Pancreatic ductal adenocarcinoma cells regulate NLRP3 activation to generate a tolerogenic microenvironment. Cancer Res Commun. 2023;3:1899\u2013911.","journal-title":"Cancer Res Commun"},{"key":"2243_CR317","doi-asserted-by":"publisher","first-page":"e2000915118","DOI":"10.1073\/pnas.2000915118","volume":"118","author":"IW Tengesdal","year":"2021","unstructured":"Tengesdal IW, Menon DR, Osborne DG, Neff CP, Powers NE, Gamboni F, Mauro AG, D\u2019Alessandro A, Stefanoni D, Henen MA, Mills TS, De Graaf DM, Azam T, Vogeli B, Palmer BE, Pietras EM, DeGregori J, Tan AC, Joosten LAB, Fujita M, Dinarello CA, Marchetti C. Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion. Proc Natl Acad Sci USA. 2021;118:e2000915118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2243_CR318","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1172\/JCI133055","volume":"130","author":"B Theivanthiran","year":"2020","unstructured":"Theivanthiran B, Evans KS, DeVito NC, Plebanek M, Sturdivant M, Wachsmuth LP, Salama AKS, Kang YB, Hsu D, Balko JM, Johnson DB, Starr M, Nixon AB, Holtzhausen A, Hanks BA. A tumor-intrinsic PD-L1\/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy. J Clin Investig. 2020;130:2570\u201386.","journal-title":"J Clin Investig"},{"key":"2243_CR319","doi-asserted-by":"publisher","first-page":"607881","DOI":"10.3389\/fimmu.2020.607881","volume":"11","author":"G Tezcan","year":"2021","unstructured":"Tezcan G, Garanina EE, Alsaadi M, Gilazieva ZE, Martinova EV, Markelova MI, Arkhipova SS, Hamza S, McIntyre A, Rizvanov AA, Khaiboullina SF. Therapeutic potential of pharmacological targeting NLRP3 inflammasome complex in cancer. Front Immunol. 2021;11:607881.","journal-title":"Front Immunol"},{"key":"2243_CR320","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1146\/annurev-immunol-101320-011235","volume":"40","author":"K Nozaki","year":"2022","unstructured":"Nozaki K, Li LP, Miao EA. Innate sensors trigger regulated cell death to combat intracellular infection. Annu Rev Immunol. 2022;40:469\u201398.","journal-title":"Annu Rev Immunol"},{"key":"2243_CR321","doi-asserted-by":"publisher","first-page":"e70100","DOI":"10.1111\/jcmm.70100","volume":"28","author":"Y Liao","year":"2024","unstructured":"Liao Y, Yang PL, Yang C, Zhuang K, Fahira A, Wang JJ, Liu ZP, Yan L, Huang ZN. Clinical signature and associated immune metabolism of NLRP1 in pan-cancer. J Cell Mol Med. 2024;28:e70100.","journal-title":"J Cell Mol Med"},{"key":"2243_CR322","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2023.13971","volume":"26","author":"K Liang","year":"2023","unstructured":"Liang K, Ke ZJ, Huang JH, Zhang XJ. Expression and clinical value of NLRP1 and NLRC4 inflammasomes in prostate cancer. Oncol Lett. 2023;26:1.","journal-title":"Oncol Lett"},{"key":"2243_CR323","first-page":"305","volume":"190","author":"L Calabrese","year":"2024","unstructured":"Calabrese L, Fiocco Z, Mellett M, Aoki R, Rubegni P, French LE, Satoh TK. Role of the NLRP1 inflammasome in skin cancer and inflammatory skin diseases, Brit. J Dermatol. 2024;190:305\u201315.","journal-title":"J Dermatol"},{"key":"2243_CR324","doi-asserted-by":"publisher","first-page":"9980","DOI":"10.18632\/aging.204438","volume":"14","author":"P Wang","year":"2022","unstructured":"Wang P, Gu YL, Yang JK, Qiu JM, Xu YQ, Xu ZX, Gao JG, Wan CD. The prognostic value of NLRP1\/NLRP3 and its relationship with immune infiltration in human gastric cancer. Aging-Us. 2022;14:9980\u201310008.","journal-title":"Aging-Us"},{"key":"2243_CR325","doi-asserted-by":"publisher","first-page":"bbaa345","DOI":"10.1093\/bib\/bbaa345","volume":"22","author":"M Ju","year":"2021","unstructured":"Ju M, Bi J, Wei Q, Jiang L, Guan Q, Zhang M, Song X, Chen T, Fan J, Li X, Wei M, Zhao L. Pan-cancer analysis of NLRP3 inflammasome with potential implications in prognosis and immunotherapy in human cancer. Brief Bioinform. 2021;22:bbaa345.","journal-title":"Brief Bioinform"},{"key":"2243_CR326","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1016\/j.ajpath.2015.07.009","volume":"185","author":"R Sorrentino","year":"2015","unstructured":"Sorrentino R, Terlizzi M, Di Crescenzo VG, Popolo A, Pecoraro M, Perillo G, Galderisi A, Pinto A. Human lung cancer-derived immunosuppressive plasmacytoid dendritic cells release IL-1\u03b1 in an AIM2 inflammasome-dependent manner. Am J Pathol. 2015;185:3115\u201324.","journal-title":"Am J Pathol"},{"key":"2243_CR327","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.1074\/jbc.M109.064907","volume":"285","author":"M Okamoto","year":"2010","unstructured":"Okamoto M, Liu W, Luo Y, Tanaka A, Cai X, Norris DA, Dinarello CA, Fujita M. Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1\u03b2. J Biol Chem. 2010;285:6477\u201388.","journal-title":"J Biol Chem"},{"key":"2243_CR328","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00005-015-0355-9","volume":"63","author":"A Miskiewicz","year":"2015","unstructured":"Miskiewicz A, Szparecki G, Durlik M, Rydzewska G, Ziobrowski I, G\u00f3rska R. The Q705K and F359L single-nucleotide polymorphisms of NOD-like receptor signaling pathway: association with chronic pancreatitis, pancreatic cancer, and periodontitis. Arch Immunol Ther Exp. 2015;63:485\u201394.","journal-title":"Arch Immunol Ther Exp"},{"key":"2243_CR329","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1755-148X.2012.01008.x","volume":"25","author":"D Verma","year":"2012","unstructured":"Verma D, Bivik C, Farahani E, Synnerstad I, Fredrikson M, Enerb\u00e4ck C, Rosdahl I, S\u00f6derkvist P. Inflammasome polymorphisms confer susceptibility to sporadic malignant melanoma. Pigment Cell Melanoma Res. 2012;25:506\u201313.","journal-title":"Pigment Cell Melanoma Res"},{"key":"2243_CR330","doi-asserted-by":"publisher","first-page":"36107","DOI":"10.1038\/srep36107","volume":"6","author":"B Guo","year":"2016","unstructured":"Guo B, Fu S, Zhang J, Liu B, Li Z. Targeting inflammasome\/IL-1 pathways for cancer immunotherapy. Sci Rep. 2016;6:36107.","journal-title":"Sci Rep"},{"key":"2243_CR331","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ccr.2008.10.011","volume":"14","author":"S Tu","year":"2008","unstructured":"Tu S, Bhagat G, Cui G, Takaishi S, Kurt-Jones EA, Rickman B, Betz KS, Penz-Oesterreicher M, Bjorkdahl O, Fox JG, Wang TC. Overexpression of interleukin-1\u03b2 induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell. 2008;14:408\u201319.","journal-title":"Cancer Cell"},{"key":"2243_CR332","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1084\/jem.20161707","volume":"214","author":"D Daley","year":"2017","unstructured":"Daley D, Mani VR, Mohan N, Akkad N, Pandian GSDB, Savadkar S, Lee KB, Torres-Hernandez A, Aykut B, Diskin B, Wang W, Farooq MS, Mahmud AI, Werba G, Morales EJ, Lall S, Wadowski BJ, Rubin AG, Berman ME, Narayanan R, Hundeyin M, Miller G. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214:1711\u201324.","journal-title":"J Exp Med"},{"key":"2243_CR333","doi-asserted-by":"publisher","first-page":"10161","DOI":"10.1158\/0008-5472.CAN-10-1921","volume":"70","author":"HW van Deventer","year":"2010","unstructured":"van Deventer HW, Burgents JE, Wu QP, Woodford R-MT, Brickey WJ, Allen IC, McElvania-Tekippe E, Serody JS, Ting JPY. The inflammasome component Nlrp3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells. Can Res. 2010;70:10161\u20139.","journal-title":"Can Res"},{"key":"2243_CR334","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1158\/0008-5472.CAN-19-2080","volume":"80","author":"S Das","year":"2020","unstructured":"Das S, Shapiro B, Vucic EA, Vogt S, Bar-Sagi D. Tumor cell-derived IL1\u03b2 promotes desmoplasia and immune suppression in pancreatic cancer. Can Res. 2020;80:1088\u2013101.","journal-title":"Can Res"},{"key":"2243_CR335","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.immuni.2010.03.003","volume":"32","author":"MH Zaki","year":"2010","unstructured":"Zaki MH, Boyd KL, Vogel P, Kastan MB, Lamkanfi M, Kanneganti T-D. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity. 2010;32:379\u201391.","journal-title":"Immunity"},{"key":"2243_CR336","doi-asserted-by":"publisher","first-page":"972","DOI":"10.4161\/auto.28374","volume":"10","author":"W Guo","year":"2014","unstructured":"Guo W, Sun Y, Liu W, Wu X, Guo L, Cai P, Wu X, Wu X, Shen Y, Shu Y, Gu Y, Xu Q. Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer. Autophagy. 2014;10:972\u201385.","journal-title":"Autophagy"},{"key":"2243_CR337","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/labinvest.2013.126","volume":"94","author":"Q Wei","year":"2014","unstructured":"Wei Q, Mu K, Li T, Zhang Y, Yang Z, Jia X, Zhao W, Huai W, Guo P, Han L. Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression. Lab Invest. 2014;94:52\u201362.","journal-title":"Lab Invest"},{"key":"2243_CR338","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/labinvest.2015.63","volume":"95","author":"Q Wei","year":"2015","unstructured":"Wei Q, Guo P, Mu K, Zhang Y, Zhao W, Huai W, Qiu Y, Li T, Ma X, Liu Y, Chen X, Han L. Estrogen suppresses hepatocellular carcinoma cells through ER\u03b2-mediated upregulation of the NLRP3 inflammasome. Lab Invest. 2015;95:804\u201316.","journal-title":"Lab Invest"},{"key":"2243_CR339","doi-asserted-by":"publisher","first-page":"702527","DOI":"10.3389\/fimmu.2021.702527","volume":"12","author":"J Wen","year":"2021","unstructured":"Wen J, Xuan B, Liu Y, Wang L, He L, Meng X, Zhou T, Wang Y. Updating the NLRC4 inflammasome: from bacterial infections to autoimmunity and cancer. Front Immunol. 2021;12:702527.","journal-title":"Front Immunol"},{"key":"2243_CR340","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cell.2018.02.055","volume":"173","author":"R Karki","year":"2018","unstructured":"Karki R, Lee E, Place D, Samir P, Mavuluri J, Sharma BR, Balakrishnan A, Malireddi RKS, Geiger R, Zhu Q, Neale G, Kanneganti T-D. IRF8 regulates transcription of Naips for NLRC4 inflammasome activation. Cell. 2018;173:920-933.e913.","journal-title":"Cell"},{"key":"2243_CR341","doi-asserted-by":"crossref","unstructured":"M Matusiak, N Van Opdenbosch, L Vande Walle, JC Sirard, TD Kanneganti, M Lamkanfi. Flagellin-induced NLRC4 phosphorylation primes the inflammasome for activation by NAIP5. Proc Natl Acad Sci USA. 2015;112:1541\u20131546.","DOI":"10.1073\/pnas.1417945112"},{"key":"2243_CR342","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1002\/cam4.1202","volume":"6","author":"X Wang","year":"2017","unstructured":"Wang X, Yang C, Liao X, Han C, Yu T, Huang K, Yu L, Qin W, Zhu G, Su H, Liu X, Ye X, Chen B, Peng M, Peng T. NLRC and NLRX gene family mRNA expression and prognostic value in hepatocellular carcinoma. Cancer Med. 2017;6:2660\u201372.","journal-title":"Cancer Med"},{"key":"2243_CR343","doi-asserted-by":"publisher","first-page":"21635","DOI":"10.1073\/pnas.1016814108","volume":"107","author":"B Hu","year":"2010","unstructured":"Hu B, Elinav E, Huber S, Booth CJ, Strowig T, Jin C, Eisenbarth SC, Flavell RA. Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc Natl Acad Sci. 2010;107:21635\u201340.","journal-title":"Proc Natl Acad Sci"},{"key":"2243_CR344","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1172\/JCI86953","volume":"126","author":"AM Janowski","year":"2016","unstructured":"Janowski AM, Colegio OR, Hornick EE, McNiff JM, Martin MD, Badovinac VP, Norian LA, Zhang WZ, Cassel SL, Sutterwala FS. NLRC4 suppresses melanoma tumor progression independently of inflammasome activation. J Clin Investig. 2016;126:3917\u201328.","journal-title":"J Clin Investig"},{"key":"2243_CR345","doi-asserted-by":"publisher","first-page":"13007","DOI":"10.1038\/ncomms13007","volume":"7","author":"R Kolb","year":"2016","unstructured":"Kolb R, Phan L, Borcherding N, Liu Y, Yuan F, Janowski AM, Xie Q, Markan KR, Li W, Potthoff MJ, Fuentes-Mattei E, Ellies LG, Knudson CM, Lee MH, Yeung SCJ, Cassel SL, Sutterwala FS, Zhang W. Obesity-associated NLRC4 inflammasome activation drives breast cancer progression. Nat Commun. 2016;7:13007.","journal-title":"Nat Commun"},{"key":"2243_CR346","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1084\/jem.20100050","volume":"207","author":"IC Allen","year":"2010","unstructured":"Allen IC, TeKippe EM, Woodford RMT, Uronis JM, Holl EK, Rogers AB, Herfarth HH, Jobin C, Ting JPY. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med. 2010;207:1045\u201356.","journal-title":"J Exp Med"},{"key":"2243_CR347","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1084\/jem.20140474","volume":"212","author":"R Allam","year":"2015","unstructured":"Allam R, Maillard MH, Tardivel A, Chennupati V, Bega H, Yu CW, Velin D, Schneider P, Maslowski KM. Epithelial NAIPs protect against colonic tumorigenesis. J Exp Med. 2015;212:369\u201383.","journal-title":"J Exp Med"},{"key":"2243_CR348","doi-asserted-by":"publisher","first-page":"100859","DOI":"10.1016\/j.mam.2020.100859","volume":"76","author":"RZ Li","year":"2020","unstructured":"Li RZ, Zhu S. NLRP6 inflammasome. Mol Aspects Med. 2020;76:100859.","journal-title":"Mol Aspects Med"},{"key":"2243_CR349","doi-asserted-by":"publisher","first-page":"1651-+","DOI":"10.1016\/j.cell.2018.09.047","volume":"175","author":"H Hara","year":"2018","unstructured":"Hara H, Seregin SS, Yang DH, Fukase K, Chamaillard M, Alnemri ES, Inohara N, Chen GY, N\u00fanez G. The NLRP6 inflammasome recognizes lipoteichoic acid and regulates gram-positive pathogen infection. Cell. 2018;175:1651-+.","journal-title":"Cell"},{"key":"2243_CR350","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1126\/science.aab3145","volume":"350","author":"PH Wang","year":"2015","unstructured":"Wang PH, Zhu S, Yang L, Cui S, Pan W, Jackson R, Zheng YJ, Rongvaux A, Sun QM, Yang G, Gao SD, Lin RT, You FP, Flavell R, Fikrig E. Nlrp6 regulates intestinal antiviral innate immunity. Science. 2015;350:826\u201330.","journal-title":"Science"},{"key":"2243_CR351","first-page":"G253","volume":"300","author":"SL Kempster","year":"2011","unstructured":"Kempster SL, Belteki G, Forhead AJ, Fowden AL, Catalano RD, Lam BY, McFarlane I, Charnock-Jones DS, Smith GCS. Developmental control of the Nlrp6 inflammasome and a substrate, IL-18, in mammalian intestine. Am J Physiol-Gastr L. 2011;300:G253\u201363.","journal-title":"Am J Physiol-Gastr L"},{"key":"2243_CR352","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.it.2019.09.005","volume":"40","author":"YS Xue","year":"2019","unstructured":"Xue YS, Tuipulotu DE, Tan WH, Kay C, Man SM. Emerging activators and regulators of inflammasomes and Pyroptosis. Trends Immunol. 2019;40:1035\u201352.","journal-title":"Trends Immunol"},{"key":"2243_CR353","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.cell.2011.04.022","volume":"145","author":"E Elinav","year":"2011","unstructured":"Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, Booth CJ, Peaper DR, Bertin J, Eisenbarth SC, Gordon JI, Flavell RA. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell. 2011;145:745\u201357.","journal-title":"Cell"},{"key":"2243_CR354","doi-asserted-by":"publisher","first-page":"969-+","DOI":"10.1016\/j.cmet.2022.05.003","volume":"34","author":"DQ Huang","year":"2022","unstructured":"Huang DQ, Singal AG, Kono Y, Tan DJH, El-Serag HB, Loomba R. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell Metab. 2022;34:969-+.","journal-title":"Cell Metab"},{"key":"2243_CR355","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.bbrc.2020.05.171","volume":"528","author":"XY Ji","year":"2020","unstructured":"Ji XY, Li LL, Lu PP, Li X, Tian D, Liu M. NLRP6 exerts a protective role via NF-kB with involvement of CCL20 in a mouse model of alcoholic hepatitis. Biochem Biophys Res Commun. 2020;528:485\u201392.","journal-title":"Biochem Biophys Res Commun"},{"key":"2243_CR356","doi-asserted-by":"publisher","first-page":"12787","DOI":"10.3748\/wjg.v21.i45.12787","volume":"21","author":"HJ Lee","year":"2015","unstructured":"Lee HJ, Yeon JE, Ko EJ, Yoon EL, Suh SJ, Kang K, Kim HR, Kang SH, Yoo YJ, Je J, Lee BJ, Kim JH, Seo YS, Yim HJ, Byun KS. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease. World J Gastroenterol. 2015;21:12787\u201399.","journal-title":"World J Gastroenterol"},{"key":"2243_CR357","doi-asserted-by":"publisher","first-page":"112177","DOI":"10.1016\/j.yexcr.2020.112177","volume":"395","author":"XY Wang","year":"2020","unstructured":"Wang XY, Wu XW, Wang QQ, Zhang Y, Wang CM, Chen JL. NLRP6 suppresses gastric cancer growth via GRP78 ubiquitination. Exp Cell Res. 2020;395:112177.","journal-title":"Exp Cell Res"},{"key":"2243_CR358","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s00109-020-01962-3","volume":"98","author":"H Xiao","year":"2020","unstructured":"Xiao H, Chen H, Jiang R, Zhang L, Wang L, Gan H, Jiang N, Zhao J, Zhai X, Liang P. NLRP6 contributes to inflammation and brain injury following intracerebral haemorrhage by activating autophagy. J Mol Med. 2020;98:1319\u201331.","journal-title":"J Mol Med"},{"key":"2243_CR359","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/ndt\/gfz169","volume":"35","author":"L Vali\u00f1o-Rivas","year":"2020","unstructured":"Vali\u00f1o-Rivas L, Cuarental L, Nu\u00f1ez G, Sanz AB, Ortiz A, Sanchez-Ni\u00f1o MD. Loss of NLRP6 expression increases the severity of acute kidney injury. Nephrol Dial Transpl. 2020;35:587\u201398.","journal-title":"Nephrol Dial Transpl"},{"key":"2243_CR360","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","volume":"16","author":"P Broz","year":"2016","unstructured":"Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 2016;16:407\u201320.","journal-title":"Nat Rev Immunol"},{"key":"2243_CR361","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/ni.3118","volume":"16","author":"SM Man","year":"2015","unstructured":"Man SM, Karki R, Malireddi RKS, Neale G, Vogel P, Yamamoto M, Lamkanfi M, Kanneganti TD. The transcription factor IRF1 and guanylate-binding proteins target activation of the AIM2 inflammasome by infection. Nat Immunol. 2015;16:467-U174.","journal-title":"Nat Immunol"},{"key":"2243_CR362","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1126\/science.aaf7532","volume":"354","author":"B Hu","year":"2016","unstructured":"Hu B, Jin CC, Li HB, Tong JY, Ouyang XS, Cetinbas NM, Zhu S, Strowig T, Lam FC, Zhao C, Henao-Mejia J, Yilmaz O, Fitzgerald KA, Eisenbarth SC, Elinav E, Flavell RA. The DNA-sensing AIM2 inflammasome controls radiation-induced cell death and tissue injury. Science. 2016;354:765\u20138.","journal-title":"Science"},{"key":"2243_CR363","doi-asserted-by":"publisher","first-page":"e45737","DOI":"10.15252\/embr.201845737","volume":"19","author":"PH Wang","year":"2018","unstructured":"Wang PH, Ye ZW, Deng JJ, Siu KL, Gao WW, Chaudhary V, Cheng Y, Fung SY, Yuen KS, Ho TH, Chan CP, Zhang Y, Kok KH, Yang W, Chan CP, Jin DY. Inhibition of AIM2 inflammasome activation by a novel transcript isoform of IFI16. Embo Rep. 2018;19:e45737.","journal-title":"Embo Rep"},{"key":"2243_CR364","doi-asserted-by":"publisher","first-page":"343-+","DOI":"10.1038\/ni.2829","volume":"15","author":"S Khare","year":"2014","unstructured":"Khare S, Ratsimandresy RA, de Almeida L, Cuda CM, Rellick SL, Misharin AV, Wallin MC, Gangopadhyay A, Forte E, Gottwein E, Perlman H, Reed JC, Greaves DR, Dorfleutner A, Stehlik C. The PYRIN domain-only protein POP3 inhibits ALR inflammasomes and regulates responses to infection with DNA viruses. Nat Immunol. 2014;15:343-+.","journal-title":"Nat Immunol"},{"key":"2243_CR365","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-016-0673-5","volume":"14","author":"Y Huang","year":"2017","unstructured":"Huang Y, Ma D, Huang HY, Lu YY, Liao Y, Liu LL, Liu XL, Fang F. Interaction between HCMV pUL83 and human AIM2 disrupts the activation of the AIM2 inflammasome. Virol J. 2017;14:1.","journal-title":"Virol J"},{"key":"2243_CR366","doi-asserted-by":"publisher","first-page":"254-+","DOI":"10.1016\/j.chom.2017.12.014","volume":"23","author":"Y Maruzuru","year":"2018","unstructured":"Maruzuru Y, Ichinohe T, Sato R, Miyake K, Okano T, Suzuki T, Koshiba T, Koyanagi N, Tsuda S, Watanabe M, Arii J, Kato A, Kawaguchi Y. Herpes simplex virus 1 VP22 inhibits AIM2-dependent inflammasome activation to enable efficient viral replication. Cell Host Microbe. 2018;23:254-+.","journal-title":"Cell Host Microbe"},{"key":"2243_CR367","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1089\/vim.2018.0058","volume":"31","author":"HT Chen","year":"2018","unstructured":"Chen HT, He GR, Chen Y, Zhang XY, Wu SP. Differential activation of NLRP3, AIM2, and IFI16 inflammasomes in humans with acute and chronic hepatitis B. Viral Immunol. 2018;31:639\u201345.","journal-title":"Viral Immunol"},{"key":"2243_CR368","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mBio.02510-18","volume":"10","author":"S Botto","year":"2019","unstructured":"Botto S, Abraham J, Mizuno N, Pryke K, Gall B, Landais I, Streblow DN, Fruh KJ, DeFilippis VR. Human cytomegalovirus immediate early 86-kDa protein blocks transcription and induces degradation of the immature interleukin-1\u03b2 protein during virion-mediated activation of the AIM2 inflammasome. Mbio. 2019;10:10.","journal-title":"Mbio"},{"key":"2243_CR369","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.celrep.2016.07.019","volume":"16","author":"T Liu","year":"2016","unstructured":"Liu T, Tang Q, Liu KP, Xie WH, Liu X, Wang HS, Wang RF, Cui J. TRIM11 suppresses AIM2 inflammasome by degrading AIM2 via p62-dependent selective autophagy. Cell Rep. 2016;16:1988\u20132002.","journal-title":"Cell Rep"},{"key":"2243_CR370","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41568-019-0123-y","volume":"19","author":"R Karki","year":"2019","unstructured":"Karki R, Kanneganti TD. Diverging inflammasome signals in tumorigenesis and potential targeting. Nat Rev Cancer. 2019;19:197\u2013214.","journal-title":"Nat Rev Cancer"},{"key":"2243_CR371","doi-asserted-by":"publisher","first-page":"45825","DOI":"10.18632\/oncotarget.17573","volume":"8","author":"M Farshchian","year":"2017","unstructured":"Farshchian M, Nissinen L, Siljam\u00e4ki E, Riihil\u00e4 P, Piipponen M, Kivisaari A, Kallajoki M, Gr\u00e9nman R, Peltonen J, Peltonen S, Quint KD, Bavinck JNB, K\u00e4h\u00e4ri VM. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma. Oncotarget. 2017;8:45825\u201336.","journal-title":"Oncotarget"},{"key":"2243_CR372","first-page":"6046","volume":"61","author":"Y Mori","year":"2001","unstructured":"Mori Y, Yin J, Rashid A, Leggett BA, Young J, Simms L, Kuehl PM, Langenberg P, Meltzer SJ, Stine OC. Instabilotyping: comprehensive identification of frameshift mutations caused by coding region microsatellite instability. Can Res. 2001;61:6046\u20139.","journal-title":"Can Res"},{"key":"2243_CR373","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/nm.3908","volume":"21","author":"JE Wilson","year":"2015","unstructured":"Wilson JE, Petrucelli AS, Chen L, Koblansky AA, Truax AD, Oyama Y, Rogers AB, Brickey WJ, Wang Y, Schneider M, M\u00fchlbauer M, Chou W-C, Barker BR, Jobin C, Allbritton NL, Ramsden DA, Davis BK, Ting JPY. Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt. Nat Med. 2015;21:906\u201313.","journal-title":"Nat Med"},{"key":"2243_CR374","doi-asserted-by":"publisher","first-page":"82ra38","DOI":"10.1126\/scitranslmed.3002001","volume":"3","author":"Y Dombrowski","year":"2011","unstructured":"Dombrowski Y, Peric M, Koglin S, Kammerbauer C, G\u00f6\u00df C, Anz D, Simanski M, Gl\u00e4ser R, Harder J, Hornung V, Gallo RL, Ruzicka T, Besch R, Schauber J. Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions. Sci Transl Med. 2011;3:82ra38.","journal-title":"Sci Transl Med"},{"key":"2243_CR375","doi-asserted-by":"publisher","first-page":"33835","DOI":"10.1074\/jbc.274.48.33835","volume":"274","author":"J Masumoto","year":"1999","unstructured":"Masumoto J, Taniguchi S, Ayukawa K, Sarvotham H, Kishino T, Niikawa N, Hidaka E, Katsuyama T, Higuchi T, Sagara J. ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells. J Biol Chem. 1999;274:33835\u20138.","journal-title":"J Biol Chem"},{"key":"2243_CR376","first-page":"6243","volume":"60","author":"BB McConnell","year":"2000","unstructured":"McConnell BB, Vertino PM. Activation of a caspase-9-mediated apoptotic pathway by subcellular redistribution of the novel caspase recruitment domain protein TMS1. Cancer Res. 2000;60:6243\u20137.","journal-title":"Cancer Res"},{"key":"2243_CR377","doi-asserted-by":"publisher","first-page":"21119","DOI":"10.1074\/jbc.C200179200","volume":"277","author":"SM Srinivasula","year":"2002","unstructured":"Srinivasula SM, Poyet JL, Razmara M, Datta P, Zhang ZJ, Alnemri ES. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem. 2002;277:21119\u201322.","journal-title":"J Biol Chem"},{"key":"2243_CR378","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/imr.12614","volume":"281","author":"A Mantovani","year":"2018","unstructured":"Mantovani A, Barajon I, Garlanda C. IL-1 and IL-1 regulatory pathways in cancer progression and therapy. Immunol Rev. 2018;281:57\u201361.","journal-title":"Immunol Rev"},{"key":"2243_CR379","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1158\/0008-5472.CAN-17-1887","volume":"78","author":"V Deswaerte","year":"2018","unstructured":"Deswaerte V, Nguyen P, West A, Browning AF, Yu L, Ruwanpura SM, Balic J, Livis T, Girard C, Preaudet A, Oshima H, Fung KY, Tye H, Najdovska M, Ernst M, Oshima M, Gabay C, Putoczki T, Jenkins BJ. Inflammasome adaptor ASC suppresses apoptosis of gastric cancer cells by an IL18-mediated inflammation-independent mechanism. Can Res. 2018;78:1293\u2013307.","journal-title":"Can Res"},{"key":"2243_CR380","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.canlet.2012.12.020","volume":"331","author":"S Hong","year":"2013","unstructured":"Hong S, Hwang I, Lee Y-S, Park S, Lee W-K, Fernandes-Alnemri T, Alnemri ES, Kim Y-S, Yu J-W. Restoration of ASC expression sensitizes colorectal cancer cells to genotoxic stress-induced caspase-independent cell death. Cancer Lett. 2013;331:183\u201391.","journal-title":"Cancer Lett"},{"key":"2243_CR381","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-019-0521-4","volume":"7","author":"E Brunetto","year":"2019","unstructured":"Brunetto E, De Monte L, Balzano G, Camisa B, Laino V, Riba M, Heltai S, Bianchi M, Bordignon C, Falconi M, Bondanza A, Doglioni C, Protti MP. The IL-1\/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreatic cancer. J Immunother Cancer. 2019;7:1.","journal-title":"J Immunother Cancer"},{"key":"2243_CR382","doi-asserted-by":"publisher","first-page":"236-+","DOI":"10.1016\/j.jid.2020.04.028","volume":"141","author":"F Magnotti","year":"2021","unstructured":"Magnotti F, Valsesia S, Gupta P, Flechtenmacher C, Contard P, Viarisio D, Venuti A, Wencker M, Tommasino M, Marvel J, Henry T. The inflammasome adaptor ASC delays UV-induced skin tumorigenesis in beta HPV38 E6 and E7 transgenic mice. J Invest Dermatol. 2021;141:236-+.","journal-title":"J Invest Dermatol"},{"key":"2243_CR383","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1620\/tjem.244.133","volume":"244","author":"T Sakaizawa","year":"2018","unstructured":"Sakaizawa T, Matsumura T, Fujii C, Hida S, Toishi M, Shiina T, Yoshida K, Hamanaka K, Ito K, Taniguchi S. Potential role of ASC, a proapoptotic protein, for determining the cisplatin susceptibility of lung cancer cells. Tohoku J Exp Med. 2018;244:133\u201344.","journal-title":"Tohoku J Exp Med"},{"key":"2243_CR384","doi-asserted-by":"publisher","first-page":"18384","DOI":"10.1073\/pnas.1209171109","volume":"109","author":"SK Drexler","year":"2012","unstructured":"Drexler SK, Bonsignore L, Masin M, Tardivel A, Jackstadt R, Hermeking H, Schneider P, Gross O, Tschopp J, Yazdi AS. Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis. Proc Natl Acad Sci USA. 2012;109:18384\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2243_CR385","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0945-053X(01)00191-3","volume":"21","author":"E Hohenester","year":"2002","unstructured":"Hohenester E, Engel J. Domain structure and organisation in extracellular matrix proteins. Matrix Biol. 2002;21:115\u201328.","journal-title":"Matrix Biol"},{"key":"2243_CR386","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1126\/science.1176009","volume":"326","author":"Richard O Hynes","year":"2009","unstructured":"Hynes Richard O. The extracellular matrix: not just pretty fibrils. Science (New York, NY). 2009;326:1216\u20139.","journal-title":"Science (New York, N.Y.)"},{"key":"2243_CR387","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1161\/CIRCRESAHA.109.207357","volume":"105","author":"C Franco","year":"2009","unstructured":"Franco C, Britto K, Wong E, Hou GP, Zhu SN, Chen M, Cybulsky MI, Bendeck MP. Discoidin domain receptor 1 on bone marrow-derived cells promotes macrophage accumulation during atherogenesis. Circ Res. 2009;105:1141-U1238.","journal-title":"Circ Res"},{"key":"2243_CR388","doi-asserted-by":"publisher","first-page":"51-+","DOI":"10.1038\/nature06887","volume":"453","author":"T L\u00e4mmermann","year":"2008","unstructured":"L\u00e4mmermann T, Bader BL, Monkley SJ, Worbs T, Wedlich-S\u00f6ldner R, Hirsch K, Keller M, F\u00f6rster R, Critchley DR, F\u00e4ssler R, Sixt M. Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature. 2008;453:51-+.","journal-title":"Nature"},{"key":"2243_CR389","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1083\/jcb.201102147","volume":"196","author":"PF Lu","year":"2012","unstructured":"Lu PF, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol. 2012;196:395\u2013406.","journal-title":"J Cell Biol"},{"key":"2243_CR390","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1084\/jem.186.12.1985","volume":"186","author":"Q Yu","year":"1997","unstructured":"Yu Q, Toole BP, Stamenkovic I. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J Exp Med. 1997;186:1985\u201396.","journal-title":"J Exp Med"},{"key":"2243_CR391","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nm.1987","volume":"15","author":"K Midwood","year":"2009","unstructured":"Midwood K, Sacre S, Piccinini AM, Inglis J, Trebaul A, Chan E, Drexler S, Sofat N, Kashiwagi M, Orend G, Brennan F, Foxwell B. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med. 2009;15:774-U711.","journal-title":"Nat Med"},{"key":"2243_CR392","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s12079-009-0075-1","volume":"3","author":"KS Midwood","year":"2009","unstructured":"Midwood KS, Orend G. The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal. 2009;3:287\u2013310.","journal-title":"J Cell Commun Signal"},{"key":"2243_CR393","first-page":"4853","volume":"51","author":"M Herlyn","year":"1991","unstructured":"Herlyn M, Graeven U, Speicher D, Sela BA, Bennicelli JL, Kath R, Guerry D. Characterization of tenascin secreted by human-melanoma cells. Can Res. 1991;51:4853\u20138.","journal-title":"Can Res"},{"key":"2243_CR394","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1158\/0008-5472.CAN-17-0064","volume":"77","author":"RS Martin","year":"2017","unstructured":"Martin RS, Pathak R, Jain A, Jung SY, Hilsenbeck SG, Pi\u00f1a-Barba MC, Sikora AG, Pienta KJ, Rowley DR. Tenascin-C and integrin \u03b19 mediate interactions of prostate cancer with the bone microenvironment. Can Res. 2017;77:5977\u201388.","journal-title":"Can Res"},{"key":"2243_CR395","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/nm.2379","volume":"17","author":"T Oskarsson","year":"2011","unstructured":"Oskarsson T, Acharyya S, Zhang XHF, Vanharanta S, Tavazoie SF, Morris PG, Downey RJ, Manova-Todorova K, Brogi E, Massagu\u00e9 J. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med. 2011;17:867-U256.","journal-title":"Nat Med"},{"key":"2243_CR396","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nm.2328","volume":"17","author":"MJ Bissell","year":"2011","unstructured":"Bissell MJ, Hines WC. Why don\u2019t we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med. 2011;17:320\u20139.","journal-title":"Nat Med"},{"key":"2243_CR397","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1038\/onc.2011.89","volume":"30","author":"JV Burnier","year":"2011","unstructured":"Burnier JV, Wang N, Michel RP, Hassanain M, Li S, Lu Y, Metrakos P, Antecka E, Burnier MN, Ponton A, Gallinger S, Brodt P. Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis. Oncogene. 2011;30:3766\u201383.","journal-title":"Oncogene"},{"key":"2243_CR398","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrm3904","volume":"15","author":"C Bonnans","year":"2014","unstructured":"Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Bio. 2014;15:786\u2013801.","journal-title":"Nat Rev Mol Cell Bio"},{"key":"2243_CR399","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/ncb2672","volume":"15","author":"J Chou","year":"2013","unstructured":"Chou J, Lin JH, Brenot A, Kim JW, Provot S, Werb Z. GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating expression. Nat Cell Biol. 2013;15:201\u201313.","journal-title":"Nat Cell Biol"},{"key":"2243_CR400","doi-asserted-by":"crossref","unstructured":"Saupe F, Schwenzer A, Jia YD, Gasser I, Spenl\u00e9 C, Langlois B, Kammerer M, Lefebvre O, Hlushchuk R, Rupp T, Marko M, van der Heyden M, Cremel G, Arnold C, Klein A, Simon-Assmann P, Djonov V, Neuville-M\u00e9chine A, Esposito I, Slotta-Huspenina J, Janssen KP, de Wever O, Christofori G, Hussenet T, Orend G. Tenascin-C downregulates Wnt inhibitor dickkopf-1. Promoting tumorigenesis in a neuroendocrine tumor model. Cell Rep. 2013;5:482\u201392.","DOI":"10.1016\/j.celrep.2013.09.014"},{"key":"2243_CR401","doi-asserted-by":"publisher","first-page":"8995","DOI":"10.3390\/ijms23168995","volume":"23","author":"LY Zhu","year":"2022","unstructured":"Zhu LY, Guo ZT, Zhang J, Yang YL, Liu CY, Zhang L, Gu ZH, Li YR, Ding ZY, Shi GY. Recombinant human arresten and canstatin inhibit angiogenic behaviors of HUVECs via inhibiting the PI3K\/Akt signaling pathway. Int J Mol Sci. 2022;23:8995.","journal-title":"Int J Mol Sci"},{"key":"2243_CR402","doi-asserted-by":"publisher","first-page":"E2915","DOI":"10.1073\/pnas.1218131110","volume":"110","author":"J Song","year":"2013","unstructured":"Song J, Lokmic Z, L\u00e4mmermann T, Rolf J, Wu C, Zhang XL, Hallmann R, Hannocks MJ, Horn N, Ruegg MA, Sonnenberg A, Georges-Labouesse E, Winkler TH, Kearney JF, Cardell S, Sorokin L. Extracellular matrix of secondary lymphoid organs impacts on B-cell fate and survival. Proc Natl Acad Sci USA. 2013;110:E2915\u201324.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2243_CR403","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1172\/JCI45817","volume":"122","author":"H Salmon","year":"2012","unstructured":"Salmon H, Franciszkiewicz K, Damotte D, Dieu-Nosjean MC, Validire P, Trautmann A, Mami-Chouaib F, Donnadieu E. Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. J Clin Investig. 2012;122:899\u2013910.","journal-title":"J Clin Investig"},{"key":"2243_CR404","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature07623","volume":"457","author":"S Kim","year":"2009","unstructured":"Kim S, Takahashi H, Lin WW, Descargues P, Grivennikov S, Kim Y, Luo JL, Karin M. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature. 2009;457:102-U108.","journal-title":"Nature"},{"key":"2243_CR405","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1002\/ijc.34674","volume":"153","author":"LE Barber","year":"2023","unstructured":"Barber LE, Bertrand KA, Sheehy S, White LF, Roy HK, Rosenberg L, Palmer JR, Petrick JL. Aspirin and nonaspirin nonsteroidal antiinflammatory drug use and occurrence of colorectal adenoma in Black American women. Int J Cancer. 2023;153:1978\u201387.","journal-title":"Int J Cancer"},{"key":"2243_CR406","doi-asserted-by":"publisher","first-page":"eabl5420","DOI":"10.1126\/sciadv.abl5420","volume":"8","author":"R De Matteis","year":"2022","unstructured":"De Matteis R, Flak MB, Gonzalez-Nunez M, Austin-Williams S, Palmas F, Colas RA, Dalli J. Aspirin activates resolution pathways to reprogram T cell and macrophage responses in colitis-associated colorectal cancer. Sci Adv. 2022;8:eabl5420.","journal-title":"Sci Adv"},{"key":"2243_CR407","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1158\/1078-0432.CCR-17-0242","volume":"23","author":"XY Dai","year":"2017","unstructured":"Dai XY, Yan J, Fu XH, Pan QM, Sun DN, Xu Y, Wang J, Nie LT, Tong LJ, Shen AJ, Zheng MY, Huang M, Tan MJ, Liu H, Huang X, Ding J, Geng MY. Aspirin inhibits cancer metastasis and angiogenesis via targeting heparanase. Clin Cancer Res. 2017;23:6267\u201378.","journal-title":"Clin Cancer Res"},{"key":"2243_CR408","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/aps.2016.39","volume":"37","author":"LJ Wang","year":"2016","unstructured":"Wang LJ, Li J, Hao FR, Yuan Y, Li JY, Lu W, Zhou TY. Dexamethasone suppresses the growth of human non-small cell lung cancer via inducing estrogen sulfotransferase and inactivating estrogen. Acta Pharmacol Sin. 2016;37:845\u201356.","journal-title":"Acta Pharmacol Sin"},{"key":"2243_CR409","doi-asserted-by":"publisher","first-page":"16703","DOI":"10.1021\/acsnano.3c03013","volume":"17","author":"MZ Li","year":"2023","unstructured":"Li MZ, Wang YY, Zhang L, Liu Q, Jiang FZ, Hou WJ, Wang YD, Fang HP, Zhang YM. Cancer cell membrane-enveloped dexamethasone normalizes the tumor microenvironment and enhances gynecologic cancer chemotherapy. ACS Nano. 2023;17:16703\u201314.","journal-title":"ACS Nano"},{"key":"2243_CR410","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S1470-2045(02)00680-0","volume":"3","author":"TA Chan","year":"2002","unstructured":"Chan TA. Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention. Lancet Oncol. 2002;3:166\u201374.","journal-title":"Lancet Oncol"},{"key":"2243_CR411","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0140-6736(03)13915-3","volume":"362","author":"G Huls","year":"2003","unstructured":"Huls G, Koornstra JJ, Kleibeuker JH. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas. Lancet. 2003;362:230\u20132.","journal-title":"Lancet"},{"key":"2243_CR412","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nrc.2016.4","volume":"16","author":"DA Drew","year":"2016","unstructured":"Drew DA, Cao Y, Chan AT. Aspirin and colorectal cancer: the promise of precision chemoprevention. Nat Rev Cancer. 2016;16:173\u201386.","journal-title":"Nat Rev Cancer"},{"key":"2243_CR413","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/CEJ.0000000000000098","volume":"24","author":"EC Yiannakopoulou","year":"2015","unstructured":"Yiannakopoulou EC. Aspirin and NSAIDs for breast cancer chemoprevention. Eur J Cancer Prev. 2015;24:416\u201321.","journal-title":"Eur J Cancer Prev"},{"key":"2243_CR414","first-page":"163","volume":"2016","author":"MJ Jiang","year":"1866","unstructured":"Jiang MJ, Dai JJ, Gu DN, Huang Q, Tian L. Aspirin in pancreatic cancer: chemopreventive effects and therapeutic potentials. Bba-Rev Cancer. 1866;2016:163\u201376.","journal-title":"Bba-Rev Cancer"},{"key":"2243_CR415","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3390\/ijms19010166","volume":"19","author":"P Pan","year":"2018","unstructured":"Pan P, Huang YW, Oshima K, Yearsley M, Zhang J, Yu J, Arnold M, Wang LS. Could aspirin and diets high in fiber act synergistically to reduce the risk of colon cancer in humans? Int J Mol Sci. 2018;19:166.","journal-title":"Int J Mol Sci"},{"key":"2243_CR416","first-page":"2449","volume":"25","author":"SP Lin","year":"2020","unstructured":"Lin SP, Pan Y, Xu CL. Effects of aspirin on pancreatic cancer cells PANC-1 and its potential molecular mechanism. J Buon. 2020;25:2449\u201355.","journal-title":"J Buon"},{"key":"2243_CR417","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11010-009-0102-9","volume":"330","author":"Q Guo","year":"2009","unstructured":"Guo Q, Wu MH, Lian P, Liao MT, Xiao ZM, Wang XY, Shen SR. Synergistic effect of indomethacin and on proliferation and invasion by human colorectal cancer cells through modulation of the Wnt\/\u03b2-catenin signaling pathway. Mol Cell Biochem. 2009;330:71\u201381.","journal-title":"Mol Cell Biochem"},{"key":"2243_CR418","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1593\/neo.06673","volume":"9","author":"E Ackerstaff","year":"2007","unstructured":"Ackerstaff E, Gimi B, Artemov D, Bhujwalla ZM. Anti-inflammatory agent indomethacin reduces invasion and alters metabolism in a human breast cancer cell line. Neoplasia. 2007;9:222\u201335.","journal-title":"Neoplasia"},{"key":"2243_CR419","doi-asserted-by":"publisher","first-page":"e22433","DOI":"10.1002\/jbt.22433","volume":"34","author":"A Seetha","year":"2020","unstructured":"Seetha A, Devaraj H, Sudhandiran G. Indomethacin and juglone inhibit inflammatory molecules to induce apoptosis in colon cancer cells. J Biochem Mol Toxic. 2020;34:e22433.","journal-title":"J Biochem Mol Toxic"},{"key":"2243_CR420","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3748\/wjg.v11.i3.340","volume":"11","author":"HM Wang","year":"2005","unstructured":"Wang HM, Zhang GY. Indomethacin suppresses growth of colon cancer via inhibition of angiogenesis. World J Gastroenterol. 2005;11:340\u20133.","journal-title":"World J Gastroenterol"},{"key":"2243_CR421","first-page":"188430","volume":"1874","author":"D Clarisse","year":"2020","unstructured":"Clarisse D, Offner F, De Bosscher K. Latest perspectives on glucocorticoid-induced apoptosis and resistance in lymphoid malignancies. Bba-Rev Cancer. 2020;1874:188430.","journal-title":"Bba-Rev Cancer"},{"key":"2243_CR422","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.prro.2022.07.003","volume":"13","author":"KN Kim","year":"2023","unstructured":"Kim KN, LaRiviere M, Macduffie E, White CA, Jordan-Luft MM, Anderson E, Ziegler M, Radcliff JA, Jones J. Use of glucocorticoids in patients with cancer: potential benefits, harms, and practical considerations for clinical practice. Pract Radiat Oncol. 2023;13:28\u201340.","journal-title":"Pract Radiat Oncol"},{"key":"2243_CR423","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/ijc.24942","volume":"126","author":"R Balansky","year":"2010","unstructured":"Balansky R, Ganchev G, Iltcheva M, Steele VE, De Flora S. Prevention of cigarette smoke-induced lung tumors in mice by budesonide, phenethyl isothiocyanate, and -acetylcysteine. Int J Cancer. 2010;126:1047\u201354.","journal-title":"Int J Cancer"},{"key":"2243_CR424","doi-asserted-by":"publisher","first-page":"e3064","DOI":"10.1038\/cddis.2017.455","volume":"8","author":"L Liu","year":"2017","unstructured":"Liu L, Aleksandrowicz E, Sch\u00f6nsiegel F, Gr\u00f6ner D, Bauer N, Nwaeburu CC, Zhao ZF, Gladkich J, Hoppe-Tichy T, Yefenof E, Hackert T, Strobel O, Herr I. Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGF\u03b2 and JNK\/AP-1. Cell Death Dis. 2017;8:e3064.","journal-title":"Cell Death Dis"},{"key":"2243_CR425","doi-asserted-by":"publisher","first-page":"540-+","DOI":"10.1038\/s41586-019-1019-4","volume":"567","author":"MMS Obradovic","year":"2019","unstructured":"Obradovic MMS, Hamelin B, Manevski N, Couto JP, Sethi A, Coissieux MM, M\u00fcnst S, Okamoto R, Kohler H, Schmidt A, Bentires-Alj M. Glucocorticoids promote breast cancer metastasis. Nature. 2019;567:540-+.","journal-title":"Nature"},{"key":"2243_CR426","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1470-2045(06)70694-5","volume":"7","author":"I Herr","year":"2006","unstructured":"Herr I, Pfitzenmaier J. Glucocorticoid use in prostate cancer and other solid tumours: implications for effectiveness of cytotoxic treatment and metastases. Lancet Oncol. 2006;7:425\u201330.","journal-title":"Lancet Oncol"},{"key":"2243_CR427","doi-asserted-by":"publisher","first-page":"101289","DOI":"10.1016\/j.xcrm.2023.101289","volume":"4","author":"AB Silver","year":"2023","unstructured":"Silver AB, Tzeng SY, Lager M, Wang JRY, Ishihara J, Green JJ, Spangler JB. An engineered immunocytokine with collagen affinity improves the tumor bioavailability, tolerability, and therapeutic efficacy of IL-2. Cell Rep Med. 2023;4:101289.","journal-title":"Cell Rep Med"},{"key":"2243_CR428","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1200\/JCO.1991.9.4.694","volume":"9","author":"JP Siegel","year":"1991","unstructured":"Siegel JP, Puri RK. Interleukin-2 toxicity. J Clin Oncol. 1991;9:694\u2013704.","journal-title":"J Clin Oncol"},{"key":"2243_CR429","first-page":"544","volume":"10","author":"DA Silva","year":"2022","unstructured":"Silva DA. An IL-2 protein therapeutic for cancer that gains function on the spot, cancer. Immunol Res. 2022;10:544\u2013544.","journal-title":"Immunol Res"},{"key":"2243_CR430","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.semcancer.2019.07.013","volume":"66","author":"L Emdad","year":"2020","unstructured":"Emdad L, Bhoopathi P, Talukdar S, Pradhan AK, Sarkar D, Wang XY, Das SK, Fisher PB. Recent insights into apoptosis and toxic autophagy: the roles of MDA-7\/IL-24, a multidimensional anti-cancer therapeutic. Semin Cancer Biol. 2020;66:140\u201354.","journal-title":"Semin Cancer Biol"},{"key":"2243_CR431","doi-asserted-by":"publisher","first-page":"114112","DOI":"10.1016\/j.addr.2022.114112","volume":"182","author":"PG Holder","year":"2022","unstructured":"Holder PG, Lim SA, Huang CS, Sharma P, Dagdas YS, Bulutoglu B, Sockolosky JT. Engineering interferons and interleukins for cancer immunotherapy. Adv Drug Deliver Rev. 2022;182:114112.","journal-title":"Adv Drug Deliver Rev"},{"key":"2243_CR432","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0169-409X(02)00027-3","volume":"54","author":"YS Wang","year":"2002","unstructured":"Wang YS, Youngster S, Grace M, Bausch J, Bordens R, Wyss DF. Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications. Adv Drug Deliver Rev. 2002;54:547\u201370.","journal-title":"Adv Drug Deliver Rev"},{"key":"2243_CR433","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1089\/10799900260442575","volume":"22","author":"SA Miles","year":"2002","unstructured":"Miles SA, Testa M, Huang J, Wade M, Carden J, Scadden DT. Lack of antitumor activity and intolerance of interleukin-4 in patients with advanced HIV disease and Kaposi\u2019s sarcoma. J Interf Cytok Res. 2002;22:1143\u20138.","journal-title":"J Interf Cytok Res"},{"key":"2243_CR434","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1158\/1078-0432.CCR-09-3122","volume":"16","author":"TB Dorff","year":"2010","unstructured":"Dorff TB, Goldman B, Pinski JK, Mack PC, Lara PN, Van Veldhuizen PJ, Quinn DI, Vogelzang NJ, Thompson IM, Hussain MHA. Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (Siltuximab), a monoclonal antibody against interleukin-6, chemotherapy-pretreated patients with castration-resistant prostate cancer. Clin Cancer Res. 2010;16:3028\u201334.","journal-title":"Clin Cancer Res"},{"key":"2243_CR435","doi-asserted-by":"publisher","first-page":"4136","DOI":"10.1182\/blood-2013-12-546374","volume":"123","author":"J San-Miguel","year":"2014","unstructured":"San-Miguel J, Blad\u00e9 J, Shpilberg O, Grosicki S, Maloisel F, Min CK, Zarzuela MP, Robak T, Prasad SVSS, Goh YT, Laubach J, Spencer A, Mateos MV, Palumbo A, Puchalski T, Reddy M, Uhlar C, Qin X, van de Velde H, Xie H, Orlowski RZ. Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma. Blood. 2014;123:4136\u201342.","journal-title":"Blood"},{"key":"2243_CR436","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.clcc.2024.05.003","volume":"23","author":"A Bessudo","year":"2024","unstructured":"Bessudo A, Haseeb AM, Reeves JA, Zhu X, Wong L, Giranda V, Suttner L, Liu F, Chatterjee M, Sharma S. Safety and efficacy of vicriviroc (MK-7690) in combination with pembrolizumab in patients with advanced or metastatic microsatellite stable colorectal cancer. Clin Colorectal Canc. 2024;23:285\u201394.","journal-title":"Clin Colorectal Canc"},{"key":"2243_CR437","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s44276-024-00057-7","volume":"2","author":"Z Quandt","year":"2024","unstructured":"Quandt Z, Jacob S, Fadlullah MZH, Wu C, Wu C, Huppert L, Levine LS, Sison P, Tsai KK, Chow M, Kang JH, Hwang J, Lee JC, Oglesby A, Venegas J, Brintz BJ, Tan AC, Anderson MS, Rosenblum MD, Young A, Daud AI. Phase II trial of pembrolizumab, ipilimumab, and aspirin in melanoma: clinical outcomes and translational predictors of response. BJC Rep. 2024;2:46.","journal-title":"BJC Rep"},{"key":"2243_CR438","doi-asserted-by":"publisher","first-page":"73","DOI":"10.36401\/JIPO-23-16","volume":"7","author":"J Ahmed","year":"2024","unstructured":"Ahmed J, Stephen B, Yang Y, Kwiatkowski E, Ejezie CL, Pant S. Phase Ib\/II study of lacnotuzumab in combination with spartalizumab in patients with advanced malignancies. J Immunother Precis Oncol. 2024;7:73\u201381.","journal-title":"J Immunother Precis Oncol"},{"key":"2243_CR439","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/jclinpath-2018-205328","volume":"72","author":"N Linder","year":"2019","unstructured":"Linder N, Taylor JC, Colling R, Pell R, Alveyn E, Joseph J, Protheroe A, Lundin M, Lundin J, Verrill C. Deep learning for detecting tumour-infiltrating lymphocytes in testicular germ cell tumours. J Clin Pathol. 2019;72:157\u201364.","journal-title":"J Clin Pathol"},{"key":"2243_CR440","doi-asserted-by":"publisher","first-page":"e6335","DOI":"10.7717\/peerj.6335","volume":"7","author":"L Aprupe","year":"2019","unstructured":"Aprupe L, Litjens G, Brinker TJ, van der Laak J, Grabe N. Robust and accurate quantification of biomarkers of immune cells in lung cancer micro-environment using deep convolutional neural networks. Peerj. 2019;7:e6335.","journal-title":"Peerj"},{"key":"2243_CR441","unstructured":"J Saltz, R Gupta, L Hou, T Kurc, P Singh, V Nguyen, D Samaras, KR Shroyer, TH Zhao, R Batiste, J Van Arnam, I Shmulevich, AUK Rao, AJ Lazar, A Sharma, V Thorsson, CGAR. Network, spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images. Cell Rep. 2018;23:181-+."},{"key":"2243_CR442","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4103\/2153-3539.189703","volume":"7","author":"R Turkki","year":"2016","unstructured":"Turkki R, Linder N, Kovanen PE, Pellinen T, Lundin J. Antibody-supervised deep learning for quantification of tumor-infiltrating immune cells in hematoxylin and eosin stained breast cancer samples. J Pathol Inform. 2016;7:38.","journal-title":"J Pathol Inform"},{"key":"2243_CR443","doi-asserted-by":"crossref","unstructured":"Q Zeng, C Klein, S Caruso, P Maille, DS Allende, B M\u00ednguez, M Iavarone, M Ningarhari, A Casadei-Gardini, F Pedica, M Rimini, R Perbellini, C Boulagnon-Rombi, A Heurgu\u00e9, M Maggioni, M Rela, M Vij, S Baulande, P Legoix, S Lameiras, DS Allende, G Amaddeo, J Argemi, S Baulande, A Beaufr\u00e8re, M Berm\u00fadez-Ramos, C Boulagnon-Rombi, J Boursier, L Bruges, J Calderaro, C Campani, S Caruso, A Casadei-Gardini, A Castano Garcia, SL Chan, A D'Alessio, L Di Tommaso, A Diaz, A Digklia, JF Dufour, G Garcia-Porrero, N Ghaffari Laleh, V Gnemmi, P Gopal, RP Graham, A Heurgu\u00e9, M Iavarone, M I\u00f1arrairaegui, JN Kather, C Klein, I Labgaa, S Lameiras, P Legoix, M Lequoy, HHW Leung, N Lom\u00e9nie, M Maggioni, P Maille, JI Mar\u00edn-Zuluaga, G Mendoza-Pacas, S Michalak, B M\u00ednguez, OSM El Nahhas, JC Nault, P Navale, M Ningarhari, V Paradis, YN Park, JM Pawlotsky, F Pedica, R Perbellini, S Peter, DJ Pinato, M Pinter, P Radu, H Regnault, M Reig, M Rela, H Rhee, L Rimassa, M Rimini, MT Salcedo, B Sangro, B Scheiner, C Sempoux, TH Su, C Torres, NH Tran, E Tr\u00e9po, M Varela, G Verset, M Vij, A Vogel, D Wendum, Q Zeng, M Ziol, L Bruges, V Gnemmi, JC Nault, C Campani, H Rhee, YN Park, M I\u00f1arrairaegui, G Garcia-Porrero, J Argemi, B Sangro, A D'Alessio, B Scheiner, DJ Pinato, M Pinter, V Paradis, A Beaufr\u00e8re, S Peter, L Rimassa, L Di Tommaso, A Vogel, S Michalak, J Boursier, N Lom\u00e9nie, M Ziol, J Calderaro. Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab\u2013bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study. Lancet Oncol. 2023;24:1411\u20131422.","DOI":"10.1016\/S1470-2045(23)00468-0"},{"key":"2243_CR444","doi-asserted-by":"publisher","first-page":"133918","DOI":"10.1016\/j.ijbiomac.2024.133918","volume":"276","author":"SH Guan","year":"2024","unstructured":"Guan SH, Xu ZZ, Yang TT, Zhang YL, Zheng YL, Chen TY, Liu HM, Zhou J. Identifying potential targets for preventing cancer progression through the PLA2G1B recombinant protein using bioinformatics and machine learning methods. Int J Biol Macromol. 2024;276:133918.","journal-title":"Int J Biol Macromol"},{"key":"2243_CR445","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","volume":"18","author":"J Vamathevan","year":"2019","unstructured":"Vamathevan J, Clark D, Czodrowski P, Dunham I, Ferran E, Lee G, Li B, Madabhushi A, Shah P, Spitzer M, Zhao SR. Applications of machine learning in drug discovery and development. Nat Rev Drug Discovery. 2019;18:463\u201377.","journal-title":"Nat Rev Drug Discovery"},{"key":"2243_CR446","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.3389\/fimmu.2020.01210","volume":"11","author":"A Romerio","year":"2020","unstructured":"Romerio A, Peri F. Increasing the chemical variety of small-molecule-based TLR4 modulators: an overview. Front Immunol. 2020;11:1210.","journal-title":"Front Immunol"},{"key":"2243_CR447","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1568026619666190122151634","volume":"19","author":"QH Wu","year":"2019","unstructured":"Wu QH, Ke HZ, Li DL, Wang Q, Fang JS, Zhou JW. Recent progress in machine learning-based prediction of peptide activity for drug discovery. Curr Top Med Chem. 2019;19:4\u201316.","journal-title":"Curr Top Med Chem"},{"key":"2243_CR448","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/carcin\/bgi327","volume":"27","author":"Y Sato","year":"2006","unstructured":"Sato Y, Takahashi S, Kinouchi Y, Shiraki M, Endo K, Matsumura Y, Kakuta Y, Tosa M, Motida A, Abe H, Imai G, Yokoyama H, Nomura E, Negoro K, Takagi S, Aihara H, Masumura K, Nohmi T, Shimosegawa T. IL-10 deficiency leads to somatic mutations in a model of IBD. Carcinogenesis. 2006;27:1068\u201373.","journal-title":"Carcinogenesis"},{"key":"2243_CR449","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/jop.12824","volume":"48","author":"F Baldan","year":"2019","unstructured":"Baldan F, Allegri L, Lazarevic M, Catia M, Milosevic M, Damante G, Milasin J. Biological and molecular effects of bromodomain and extra-terminal (BET) inhibitors JQ1, IBET-151, and IBET-762 in OSCC cells. J Oral Pathol Med. 2019;48:214\u201321.","journal-title":"J Oral Pathol Med"},{"key":"2243_CR450","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.canlet.2017.02.021","volume":"394","author":"AS Leal","year":"2017","unstructured":"Leal AS, Williams CR, Royce DB, Pioli PA, Sporn MB, Liby KT. Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer. Cancer Lett. 2017;394:76\u201387.","journal-title":"Cancer Lett"},{"key":"2243_CR451","doi-asserted-by":"publisher","first-page":"581-+","DOI":"10.1038\/s41586-020-2040-3","volume":"579","author":"A Vasanthakumar","year":"2020","unstructured":"Vasanthakumar A, Chisanga D, Blume J, Gloury R, Britt K, Henstridge DC, Zhan YF, Torres SV, Liene S, Collins N, Cao EY, Sidwell T, Li CR, Spallanzani RG, Liao Y, Beavis PA, Gebhardt T, Trevaskis N, Nutt SL, Zajac JD, Davey RA, Febbraio MA, Mathis D, Shi W, Kallies A. Sex-specific adipose tissue imprinting of regulatory T cells. Nature. 2020;579:581-+.","journal-title":"Nature"},{"key":"2243_CR452","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/s42003-024-06566-y","volume":"7","author":"HR Wang","year":"2024","unstructured":"Wang HR, Zhang Y, Mo YJ, Zhang Z, Chen R, Lu XB, Huang W. Reshaping tumor microenvironment by regulating local cytokines expression with a portable smart blue-light controlled device. Commun Biol. 2024;7:916.","journal-title":"Commun Biol"},{"key":"2243_CR453","doi-asserted-by":"publisher","first-page":"116283","DOI":"10.1016\/j.bcp.2024.116283","volume":"228","author":"S Mazumder","year":"2024","unstructured":"Mazumder S, Bindu S, Debsharma S, Bandyopadhyay U. Induction of mitochondrial toxicity by non-steroidal anti-inflammatory drugs (NSAIDs): the ultimate trade-off governing the therapeutic merits and demerits of these wonder drugs. Biochem Pharmacol. 2024;228:116283.","journal-title":"Biochem Pharmacol"},{"key":"2243_CR454","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s000660050027","volume":"175","author":"M Mariotta","year":"1999","unstructured":"Mariotta M, Perewusnyk G, Koechli OR, Little JB, Doeberitz MV, Mirimanoff RO, Rutz HP. Dexamethasone-induced enhancement of resistance to ionizing radiation and chemotherapeutic agents in human tumor cells. Strahlenther Onkol. 1999;175:392\u20136.","journal-title":"Strahlenther Onkol"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02243-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02243-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02243-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:30:13Z","timestamp":1740382213000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-025-02243-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":454,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2243"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02243-8","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"assertion":[{"value":"10 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}